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Part 1:  Summary 
English 
Aerobic organisms require oxygen to produce ATP, the energy unit of the cells. To 
ensure adequate ATP production, cells developed several different adaptation 
processes to meet variations in oxygen supply. Central in the molecular adaptation is 
the hypoxia-inducible factor HIF, a transcription factor that regulates the expression 
of several dozens of target genes that are involved in systemic as well as cellular 
adaptation processes. HIF belongs to the basic helix-loop-helix/Per-ARNT-Sim 
(bHLH/PAS) family of transcription factors and is composed of a constantly 
expressed HIF-β and an oxygen-labile HIF-α subunit [3]. The HIF-α subunit is tightly 
regulated by a family of HIF proly-4-hydroxylases (PHDs) that use oxygen as 
substrate to hydroxylate two prolines in a LxxLAP motif within the HIF-α protein 
enabling pVHL-mediated E3 ubiquitin ligase binding resulting in HIF-α 
ubiquitination and proteasomal degradation [3-5]. There are three major PHD 
isoforms termed PHD1, PHD2 and PHD3. PHD2 is thought to be the key regulator of 
HIF-α [6, 7]. 
In the work presented herein we attempted to find novel PHD2-interacting proteins. 
Using yeast 2-hybrid methodology, we discovered three novel PHD2 interactors: 
helicase with zinc finger domain (HELZ), zinc finger and BTB domain containing 
protein (ZBTB) 3 and KIAA0556. Bioinformatic analysis revealed that HELZ, similar 
to HIF-α, has two highly conserved LxxLAP domains. However, in contrary to HIF-
α, HELZ protein levels were not regulated by the PHD function. Furthermore, 
hypoxia had no effect on HELZ mRNA levels as well as subcellular localization and 
HELZ was not involved in the regulation of HIF-transcriptional activity. 
To ensure proper function, cells developed adaptation mechanisms allowing rapid 
response to change in their physiological environment. Protein translation plays a 
central role in these adaption processes, since it allows an immediate response even 
when gene transcription is lacking. Translation initiation, the rate limiting step of 
protein translation, involves many proteins including initiation factors, ribosomal 
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subunits and general RNA binding proteins. One key player in this regulation is the 
poly(A) binding protein (PABP) that binds to the poly(A) tail of all poly-adenylated 
mRNAs and brings about their circularization, a process that facilitates translation 
initiation [8, 9]. We found that HELZ associates with PABP via its PAM2 motif, a 
protein interaction motif found in various PABP interactors [10]. Furthermore, 
interaction with PABP suggested a role for HELZ in protein translation, in particular 
in translation initiation. Indeed, siRNA-mediated HELZ knock down reduced and 
transient overexpression of HELZ induced the translation of a heterologous luciferase 
gene reporter as well as general protein translation. This stimulatory function was 
independent of the HELZ helicase function as well as the prolines found within the 
HELZ LxxLAP motifs as demonstrated by site-directed mutagenesis analysis. In 
addition, polysomal shift analysis revealed impaired translation initiation in HELZ-
silenced HeLa cells supporting the notion that HELZ functions in translation 
initiation. Mechanistically, we were able to show that HELZ promotes cell 
proliferation and most strikingly, HELZ strongly impairs ribosomal protein S6 
phosphorylation without affecting S6 protein expression. 
In summary, we suggest a role for HELZ as novel translation initiation factor that 
promotes cell proliferation as well as S6 phosphorylation.   
 
Summary 
Deutsch 
 
Aerobe Organismen benötigen Sauerstoff um ATP zu produzieren. Um eine adäquate 
ATP Produktion zu gewährleisten, haben Zellen im Laufe der Evolution 
Anpassungsprozesse an die sich verändernde Sauerstoffverfügbarkeit entwickelt. In 
der molekularen Anpassung ist der Hypoxie-induzierbare Transkriptionsfaktor HIF 
zentral. HIF reguliert die Expression einer grossen Anzahl von Zielgenen, die in den 
systemischen sowie zellulären Anpassungsvorgängen eine Rolle spielen. HIF ist ein 
heterodimerer Proteinkomplex, der sich aus einer konstitutiv exprimierten HIF-β und 
einer sauerstoffregulierten HIF-α Untereinheit zusammensetzt. Die Stabilität der 
HIF-α Untereinheit wird von einer Familie von HIF Prolyl-4-Hydroxylasen (PHDs) 
reguliert. Diese Enzyme verwenden Sauerstoff als Substrat, um zwei spezifische 
Proline, die in einem konservierten LxxLAP Sequenzmotif im HIF-α vorkommen, zu 
hydroxylieren. Diese Hydroylierung ermöglicht wiederum die Bindung des von 
Hippel-Lindau Proteins an die HIF-α Untereinheit, was zur Ubiquitinierung und dem 
darauffolgenden Abbau der HIF-α Untereinheit im Proteasom führt. Die PHD 
Enzymfamilie besteht aus drei Hauptisoformen: PHD1, PHD2 und PHD3. Obwohl 
alle drei Isoformen HIF-α hydroxylieren können, deuten verschiedene Studien darauf 
hin, dass die PHD2 Isoform der zentrale HIF-α Regulator ist. 
Mit dem Ziel weitere Interaktionspartner von PHD2 zu identifizieren, haben wir eine 
Hefe Zwei-Hybrid Durchforstung durchgeführt und drei noch unbekannte PHD2 
Interaktoren gefunden: Die Helikase mit einer Zinkfinger Domäne (HELZ), das 
Zinkfinger und BTB-Domänen Protein (ZBTB) 3 und KIAA0556. Eine 
bioinformatische Analyse dieser neuen Interaktoren hat ergeben, dass HELZ, ähnlich 
zu HIF-α, zwei konservierte LxxLAP Motife enthält. Die HELZ Proteinmenge wird 
jedoch nicht durch die PHDs reguliert. Hypoxie hat keinen Einfluss auf die HELZ 
mRNA Mengen und auch nicht auf die subzelluläre Lokalisierung von HELZ. Auch 
hat HELZ keinen Einfluss auf die transkriptionelle Aktivität von HIF. 
Um eine einwandfreie Zellfunktion sicherzustellen, haben Zellen Anpassungsmecha-
nismen entwickelt, die eine schnelle Anpassung an sich ändernde physiologische Be-
dingungen ermöglicht. Die Proteintranslation spielt eine zentrale Rolle in diesen 
Anpassungsvorgängen, da diese eine schnelle Reaktion, sogar bei fehlender 
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Gentranskription, ermöglicht. Die Translationsinitiierung ist der limitierende Faktor in 
der Proteintranslation und umfasst eine Vielzahl von Proteinen, unter anderem Initia-
tionsfaktoren, ribosomale Untereinheiten und RNA-Bindungsproteine. Eine 
Schlüsselrolle in diesem Prozess spielt das Poly(A)-Bindungsprotein (PABP), das 
spezifisch zum Poly(A)-Schwanz aller polyadenlylierter mRNA bindet. Diese 
Bindung unterstützt die Zirkularisation der mRNA, ein Vorgang, der die 
Translationsinitiierung unterstützt. Wir haben festgestellt, dass HELZ durch sein 
PAM2 Motif - ein Proteinbindungsmotif das in verschiedenen PABP-Interaktoren 
vorkommt - mit PABP interagiert. Diese Interaktion deutet auf eine Funktion von 
HELZ in der Proteintranslationsinitiierung hin. Die siRNA-vermittelte 
Herunterregulation von HELZ reduzierte, und die transiente Überexpression von 
HELZ induzierte die Expression eines heterologen Luziferase Reportergens ohne den 
Luziferase mRNA Pegel zu verändern, was eine Rolle von HELZ in der generellen 
Proteintranslation vermuten lässt. Auch wurde in Bezug auf die generelle 
Proteintranslation eine stimulierende Funktion von HELZ gemessen. Diese indu-
zierende Wirkung von HELZ auf die Proteintranslation ist unabhängig von der 
Interaktion von HELZ mit PABP, sowie von der Präsenz der Proline in den HELZ 
LxxLAP Motifen. Auch bestätigte eine Polysomenshiftanalyse von HeLa Zellen, die 
reduzierte HELZ Proteinmengen vorweisen, eine Rolle von HELZ in der 
Proteintranslation. 
Im Weiteren konnten wir zeigen, dass HELZ die Zellproliferation stimuliert und 
interessanterweise auch die Phosphorylierung des ribosomalen Proteins S6, ohne 
dessen Gesamtmenge zu beeinträchtigen. 
Zusammenfassend schlagen wir eine Funktion von HELZ als neuen 
Translationsinitiationsfaktor, der das Zellwachstum sowie die Phosphorylierung des 
ribosomale Proteins S6 stimuliert, vor.  
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Part 2:  Abbreviations 
(A)-site  Acceptor site 
(E)-site  Exit site 
(P)-site   Peptidyl site 
AMP Adenosine monophosphate 
ATP Adenosine triphosphate 
bHLH    basic helix-loop-helix 
cAMP   cyclic AMP 
CBP   CREB-binding protein 
cDNA   complementary DNA  
CO2   Carbon dioxide 
CREB   cAMP response element-binding protein 
Da   Dalton 
Dbp   DEAD box protein 
DNA   Deoxyribonucleic acid 
DRHC   Down-regulated in human cancer 
eEF   Eukaryotic elongation factor 
EGL  Egg-laying abnormal     
eIF   Eukaryotic initiation factor  
EPO   Erythropoietin 
FIH   Factor inhibiting HIF 
FKBP   FK506-binding protein 
GDP   Guanosine diphosphate 
GTP   Guanosine triphosphate 
HELZ    Helicase containing a zinc finger   
HIF   Hypoxia-inducible factor 
HRE   Hypoxia-responsive element 
iPABP inducible PABP   
MAPK   Mitogen-activated protein kinase 
mRNA  messenger RNA 
mTOR   mammalian target of rapamycin 
NMD   Nonsense-mediated decay 
NTP   Nucleosid triphosphate 
ODD   Oxygen-dependent degradation 
PABP   Poly(A) binding protein 
Pam   Poly(A)-interaction motif 
PAS      Per, Arnt, Sim  
PHD   Prolyl -4-hydroxylase domain-containing protein 
Poly(A)  Poly adenylated 
Prp   Pre-mRNA-processing protein 
pVHL   Von-Hippel Lindau protein 
RNA   Ribonucleic acid 
RNP   Ribonucleoproteins 
RRM   RNA recognition motif 
rRNA   ribosomal RNA 
SF   Superfamily 
SIAH Seven in absentia homolog 
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TAD Transactivation domain 
tPABP   testis PABP 
tRNA   transfer RNA 
UAP   U2AF65-associated protein 
UPF   Up-frameshift 
UTR   Untranslated region 
UvrD    UV-resistant D 
IRP   Iron regulatory protein 
ATF   Activating transcription factor 
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Part 3:  Introduction 
RNA helicases 
The term helicase describes enzymes that unwind deoxyribonucleic acid (DNA) and 
Ribonucleic acid (RNA) duplexes in a nucleosidetriphosphate (NTP)-dependent 
fashion [11]. RNA helicases are found in viruses, bacteria, archaea and eukaryotes, 
where they are the largest group of enzymes involved in RNA metabolism [12]. They 
play a role in almost all areas of RNA processing such as messenger RNA (mRNA) 
translation, ribosome synthesis, RNA maturation, nuclear export, etc. [13]. 
One of the first described helicases was the eukaryotic translation initiation factor 
(eIF) 4A. In 1985, a research team lead by Nahum Sonnenberg incubated eIF4A 
protein together with globin mRNA and as a result observed an increase in nuclease 
sensitivity of the globin mRNA. This experiment suggested that eIF4A can unwind 
the mRNA structure. Adenosine triphosphate (ATP) was required for this reaction 
[14].  
3.1 Classification 
Helicases are identified based on the sequence similarity of seven conserved motifs 
called “helicase signature motifs” and are classified based on the organization and 
similarity of those motifs into three large superfamilies and two smaller families [15]. 
Superfamilies 1 and 2 (SF1 and SF2) contain all seven motifs whereas superfamily 3 
(SF3) contains only three [16]. In Figure 1 the motifs of the three superfamilies with 
the corresponding consensus sequences are depicted. 
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Figure 1: Schematic diagrams representing proteins from each of the three helicase superfamilies with the N-termini on the left 
and C-termini on the right. In all family consensus sequences, a ‘+’ represents a hydrophobic residue, an ‘o’ represents a 
hydrophilic residue and an ‘x’ represents a residue that is not restricted to being hydrophobic or hydrophilic. [17] 
 
The seven motifs of SF1 and SF2 are usually found within a region of 200–700 amino 
acids called the “core region” [18]. The sequence between the motifs is highly 
variable but the length is mostly conserved. The C- and N-terminal regions are highly 
variable. Most of these motifs are involved in NTP binding or hydrolysis to unwind 
double-stranded nucleic acid. In Figure 2 the motifs with their corresponding 
functions are depicted. 
  
 
 
 
 
 
 
 
 
Figure 2: Conserved sequence motifs of SF1 and SF2 RNA helicases and their functions. [19] 
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Even though SF1 and SF2 harbor all seven helicase key motifs they are nevertheless 
easy distinguishable since some of their seven motifs do not share sequence similarity 
and they also differ in the localization of some of the motifs on the enzyme. 
Furthermore, sequence comparison of yeast SF1 RNA helicases revealed two 
additional SF1-specifc motifs and RNA helicases that contain these additional motifs 
may belong to a subset of the SF1 that are specifically involved in RNA-dependent 
processes [20].   
It is important to note that the sequence comparison only allows establishing families 
of related proteins but do not assign a specific function to the protein. Therefore, as 
long as a helicase function has not been proven experimentally, the functionality of a 
putative RNA helicase has to be questioned.  
Two motifs, that are common and highly conserved between the superfamilies, are the 
Walker A (phosphate-binding (P)-loop) and Walker B (Mg2+-binding aspartic acid) 
motifs [21]. These are also found in many NTPase-containing enzymes [22]. 
3.1.1 Walker A motif 
The Walker A motif is crucial for the ATPase and helicase function. For example, 
mutation of the first alanine residue in the Walker A region of eIF4A to valine or 
mutation of a conserved lysine to asparagine abolished its ATPase and unwinding 
activity completely [23]. The Walker A motif contains the consensus sequence 
(G/A)xxxxGK(T/S) (where x is any amino acid) [24]. 
8.1.1 Walker B motif 
The Walker B motif contains the consensus DExx. Mutation of either the aspartic or 
glutamic acid residue abolishes the ATP binding and hydrolysis function [23]. The 
glutamic acid is thought to function as the catalytic base in the ATP hydrolysis [24]. 
8.1.2 Superfamily 1 
SF1 helicases are found throughout all kingdoms even including viruses [25]. The 
best characterized member of this group is up-frameshift (Upf) 1, an enzyme required 
for nonsense-mediated mRNA decay (NMD) [26]. SF1 consists of three families: 
UV-resistantD/replication (UvrD/Rep), petite integration frequency 1(Pif1)-like and 
Upf1-like and only the Upf1-like family contains RNA helicases [1, 27] (Figure 3). 
This Walker B motif of SF1 includes the consensus DExx [16]. 
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Figure 3: SF1 andSF2 helicase families. Unrooted 
cladogram showing the families of the SF1 and the 
SF2. Families containing RNA helicases are written in 
bold. Uvr, UV-resistant; Rep, replication; Pif, petite 
integration frequency; Rec, recombination; Rad, 
radiation; XPD, xeroderma pigmentosum 
complementation; Ski, superkiller; Swi, switching; Snf, 
sucrose non-fermenting; RIG, retinoic acid-inducible 
gene; RH, RNA helicase; NS, non-structural; NPH, 
nucleoside triphosphate phosphohydrolase. [1] 
 
 
 
 
 
 
3.1.2 Superfamily 2 
The superfamily 2 is the largest superfamily, and most eukaryotic RNA helicases 
belong to this superfamily. Based on its Walker B motif consensus sequence it is also 
termed DExH/D helicase family [16]. It consists of 10 families, five of which 
(DEAD-box, DEAH/RHA, superkiller (Ski) 2-like, retinoic acid-inducible gene 
(RIG)-I-like, and viral DExH proteins and the non-structural/nucleoside triphosphate 
phosphohydrolase (NS3/NPH)-II family) contain mainly RNA helicases and are 
therefore called “RNA helicase”-families [1, 27] [Figure 3]. For the remaining five 
families no RNA helicases have been identified.  
3.1.3 Superfamily 3 
In contrast to SF1 and SF2, SF3 contains only four conserved helicase domains 
including the Walker A and B motifs. Members of this superfamily were originally 
identified in RNA and DNA viruses and there are no SF3 helicases encoded in the 
cellular genomes [28-30]. 
3.2 Function of RNA helicases 
RNA helicases are involved in almost all aspects of RNA metabolism such as 
transcription, translation initiation, ribosome biogenesis, nuclear mRNA export, RNA 
degradation and stabilization, and nuclear and mitochondrial RNA processing for 
example splicing [31] (Figure 4). Roles of RNA helicases have also been implicated 
in cell growth and differentiation [31] 
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RNA helicases have been originally defined on their capability to use the energy of 
NTP to unwind RNA duplexes. However, this unwinding activity has only been 
demonstrated so far in vitro. In the past years is has become clear that the function of 
RNA helicases is not limited to RNA strand separation but also include the 
displacement of proteins from RNA molecules, annealing of RNA strands, and 
stabilization of on-pathway folding intermediates. 
In yeast, the majority of RNA helicases are involved in ribosome biogenesis and pre-
mRNA splicing and many of them have homologs in eukaryotic cells [32]. This is not 
surprising since both processes require large ribonucleoproteins (RNPs).   
3.2.1 Translation 
 The role of RNA helicases in mRNA translation (including translation initiation, 
elongation and termination) has been the subject of intense research in the last few 
years. Eukaryotic translation initiation of most mRNAs begins with the association of 
the 40S ribosomal subunit and the subsequent scanning for the initiation codon AUG 
[33]. This process is also controlled by the secondary structures of the mRNA in the 
5’-untranslated region (UTR) since they must be unwind for optimal translation 
initiation [34]. The first RNA helicase described to play a role in translation initiation 
is the eIF4A [35]. It has been shown that eIF4A facilitates unwinding of 5’-UTR 
Figure 4: Cellular roles of eukaryotic 
RNA helicases. Selected, basic 
processes of eukaryotic RNA 
metabolism are represented by the white 
circles, as indicated by the callouts. The 
grey lines mark connections between 
processes. The colored circles represent 
the number of individual RNA helicases 
involved in a given process. RNA 
helicases (yeast and human orthologs) 
are grouped and color-coded according 
to their families (see legend at left lower 
corner). Connectors indicate 
involvement in one or more processes 
of RNA metabolism. Circles with bold 
lines emphasize the three RNA 
helicases (Prp22p, Prp43p, eIF4A-III) 
for which specific binding site 
information is available. [1] 
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secondary structures. Since then other RNA helicases have been described to play a 
role in initiation such as the RNA helicase DDX3 [36]. Recently, DHX29 has been 
described to play a role in translation of mRNAs harboring highly structured 5’-UTRs 
[37]. 
3.2.2 Nuclear export   
Given that mRNAs are synthesized in the nucleus but translated within the cytoplasm 
they need to be translocated from the nucleus to the cytoplasm. Several RNA 
helicases are involved in this process. For instance, the human RNA helicase 
U2AF65-associated protein (UAP) 56 is a component of the transcription-export 
(TREX) complex and knock down of UAP56 results in accumulation of mRNAs in the 
nucleus [38, 39]. DEAD-box protein (Dbp) 5p, another RNA helicase, is suggested to 
play a role in releasing RNPs upon arrival in the cytoplasm and in coupling RNP 
export and translation [40]. The cap-binding protein eIF4E is involved in the nuclear 
export of a family of proliferation-related mRNAs that share a 50-nucleotide sequence 
element in their 3'-UTR [41]. 
3.2.3 Degradation 
Messenger RNA decay is a highly regulated process playing a vital role in protein 
translation by way of regulation of the mRNA turnover rate. Furthermore, mRNAs 
harboring premature termination (nonsense) codons are degraded through a process 
termed nonsense-mediated mRNA decay (NMD) and fill as such an important 
function in protein translation surveillance. Many RNA helicases assist in these 
processes. For instance, the DExD/H-box helicase (DHH) 1 stimulates the mRNA 
decapping which is the initial step of RNA degradation [42]. The most prominent 
helicase involved in NMD is the SF 1 RNA helicase regulator of nonsense transcript 
(Rent) 1 [43]. Another helicase that plays a role in NMD is the RNA helicase DDX48, 
a member of the exon junction complex [44].  
3.2.4 Transcription 
A few RNA helicases have a function in gene transcription. It has been proposed that 
the cyclic adenosine monophosphate (cAMP) response element-binding protein 
(CBP) stimulates the expression of certain signal-dependent genes via its association 
with RNA polymerase II complexes [45]. The formation of the CBP-RNA polymerase 
II complex requires the RNA helicase A, and mutation of its helicase function reduces 
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cAMP response element binding (CREB)-dependent transcription [46]. P68, one of 
the first validated RNA helicases , acts as a transcriptional coactivator for the nuclear 
receptor estrogen receptor (ER) α [47]. Although the exact mechanism concerning the 
involvement of RNA helicases in transcription is not known, it is thought that most of 
them operate mainly as adaptors or bridges between factors in the transcriptional 
machinery [48]. 
3.2.5 Pre-mRNA splicing 
One step in the correct formation of mRNA is the removal of introns from the mRNA 
precursors [49]. It is a multistep process initiated by the formation of a large RNA-
protein complex, known as the spliceosome on the mRNA precursor [50, 51]. Many 
helicases play a fundamental role in this process. For example, p68 has been found to 
be part of an in vitro-reconstituted spliceosome, and depletion of p68 abolished the 
formation of the spliceosome [52, 53]. Other examples are the RNA helicases pre-
RNA processing protein (Prp) 22p and Prp16p that use the energy of NTP hydrolysis 
to resolve RNA secondary structures within the spliceosome [54, 55]. 
3.2.6 Ribosomal biogenesis 
Ribosomal biogenesis is a highly complex multistep process that leads to the 
formation of the ribosomal subunits. It involves over seventy ribosomal proteins, four 
ribosomal RNA (rRNA) molecules and several transacting factors. Most of the known 
RNA helicases are involved in these processes. For examples the RNA helicases 
Dbp6p, Dbp7p and suppressor of polyadenylated binding protein 1 (Spb) 4p are 
required for the 60S ribosomal subunit assembly in Saccharomyces cerevisiae [56-
58]. Factor four A-like (Fal) 1p, another RNA helicase, leads to decreased 18S rRNA 
levels leading to an overall deficit in 40S ribosomal subunits [59].  
3.3 RNA helicase HELZ 
3.3.1 Introduction 
Based on sequence comparison analysis, HELZ (HELicase with Zinc finger motif) 
was assigned to the DNA2/nuclear accommodation of mitochondria 7 (DNA2/NAM7) 
helicase family of the superfamily 1 of RNA helicases. Additional members of this 
family include, among others, moloney leukemia virus (Mov) 10, Zinc finger (ZNF) 
X1 and Upf1. HELZ is alternatively called KIAA0054 or DRHC (Down-Regulated in 
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Human Cancer) [60, 61]. The HELZ gene is located on chromosomal band 17q25.1. 
The HELZ protein consists of 1942 amino acids, thus yielding a molecular weight of 
approximately 220 000 Daltons (Da).  
3.3.2 Structure 
In addition to the classical RNA helicase motifs, HELZ harbors a CCCH-Zinc finger 
at its N-terminal end. Furthermore, two conserved LxxLAP motifs can be detected at 
its C-terminal end, and a sequence comparison analysis identified a polyadenylated 
binding protein (PABP) association motif (PAM) 2 motif within the HELZ protein 
[10].  
3.3.3 Function 
The function of HELZ is poorly understood. The first published report on HELZ dates 
back to 1994 when a full-length HELZ complementary (c)DNA termed KIAA0054 
was isolated from a human immature myeloid cell line cDNA library [60]. The cDNA 
encoded for a 1942 amino acid long protein and from the structure it was inferred that 
it contains a Walker A motif. Also, Northern blot analysis revealed ubiquitous 
expression of HELZ [60]. In 1999, Wagner et al. found that HELZ contains several 
motifs characteristic of members of the RNA helicase SF 1, including a putative 
purine nucleotide-binding site [62]. The study also identified the mouse homolog of 
HELZ and found widespread spatial and temporal expression throughout murine 
embryonic development [62]. Already a year later a research team from the Robert 
Wood Johnson Medical School in New Jersey aimed to identify novel Upf1 
homologues by performing sequence comparisons. The group determined HELZ to 
belong to the Upf1-like subclass of helicases and observed the protein to contain, 
besides the classical seven RNA helicase signature motifs, two additional motifs [20]. 
It has been suggested that members of this subgroup might play a role in RNA-
dependent processes [20]. In 2003, a research group from Japan showed reduced 
HELZ mRNA expression in 28 out of 95 (29%) cell lines derived from a variety 
of human cancers [61]. Based on this finding HELZ was newly termed DRHC [61]. 
Furthermore, transfection of a DRHC expression vector inhibited growth of cancer 
cells in liquid medium or soft agar, suggesting a tumor suppressor function of HELZ 
[61]. Since then, two other reports have been published showing the 
methyltransferases SET and MYND domain (SMYD) 2 and SMYD3 to form a 
Introduction RNA helicases  
 21 
ternary complex with RNA polymerase II and HELZ, suggesting a role for HELZ in 
gene transcription [63, 64].  
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Protein translation 
3.4 Introduction 
Translation is the last step in the conversion of DNA to protein where mRNA 
nucleotide sequence is decoded into a protein sequence. Translation is highly 
regulated since the smallest mistake could lead to a malfunctioning or non-functioning 
protein. Also, regulation at this level allows the rapid response to a change in the 
physiological condition of the cell, since the transcriptional machinery does not need 
to be turned on and the response can occur much more quickly at mRNA level.   
3.5 Messenger RNA structure 
The majority cellular mRNAs contain a 5‘-cap structure composed of a tri-phosphate-
linked 7-methylguanosine (i.e. m7G), and except for most histones, a polyadenylated 
(poly)(A) tail of about 50-300 nucleotides in length [65]. Specific proteins of the 
translational machinery recognize this structure and alteration in the structure may 
lead to inefficient translation of the specific mRNA [66]. For example, eIF4E is able 
to bind to the 5’-cap and depletion of eIF4E drastically reduces cap-dependent 
translation [67, 68]. Messenger RNAs may contain secondary structures (mainly 
hairpins) within their 5’-UTR and mRNA translation efficiency is also dependent on 
the stability and position of these secondary structures [69].  
3.6 Process 
Translation can be broken down into four stages: initiation, elongation, termination, 
and recycling. For most mRNAs, translation starts with the binding of the 43S 
preinitiation complex to the cap of the mRNA followed by the scanning in 3’ 
direction until a start codon (AUG) is recognized. In the next step, the 40S ribosome 
assembles with a initiator-methionyl-transfer-RNA (Met-tRNAiMet) in its peptidyl 
(P)-site at the start codon and joins with the 60S ribosome to create the translationally 
active 80S initiation complex. Once the initiation complex is assembled elongation 
begins. During elongation, the nucleotide codon of the mRNA is translated within the 
ribosome to a polypeptide chain. Once a stop codon is reached, elongation is 
terminated and the 80S ribosomal complex is dissociated, preparing the ribosomal 
subunits for a new round of translation. 
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3.6.1 Initiation 
Translation initiation is multistep process involving the 40S and 60S ribosomal 
subunits and several eukaryotic translation initiation factors [70]. Initially, the 43S 
preinitiation complex (comprising a 40S subunit, the eIF2–GTP–Met-tRNAMeti 
ternary complex and several eukaryotic initiation factors including eIF1, 1A, 2, 3, and 
5) attaches to the 5‘-cap of the mRNA through interaction with the trimeric eI4F 
scaffold (comprising eIF4A, eIF4E and eIF4G), notably with the rate-limiting 
initiation factor eIF4E that directly binds to the cap [71]. Next, the 43S complex scans 
along the 5‘-UTR in 5‘-3‘direction until it reaches the initiation codon AUG [33]. 
eIF4A assists in this process since it functions as a RNA helicase unwinding 
secondary structures [72]. Translation initiation efficiency is further enhanced through 
the interaction of the eIF4F complex with the poly(A) binding protein (PABP) that 
results in the circularization of the mRNA [8]. How this process leads to enhanced 
mRNA translation is not yet fully understood. Because PABP interacts with the 
eukaryotic release factor (eRF) 3, it has been suggested that circularization of the 
mRNA ameliorates ribosomal subunit recycling for the translation initiation of the 
same mRNA [9]. Also, eIF4F affinity for the cap is enhanced through the 
circularization of the mRNA [73]. Another report suggests that 60S subunit joining is 
enhanced through the interaction of PABP with eIF4F [74]. After initiation, codon 
recognition, and 48S complex formation, eIF5 and eIF5B promote the hydrolysis of 
eIF2-bound guanosine tri-phosphate (GTP), the displacement of the eIFs and the 
joining of a 60S subunit to form the active translational complex 80S [75]. The 
different initiation steps are summarized in Figure 5. 
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8.1.3 Elongation 
Three positions are known to exist in the ribosome for the binding of tRNA: the 
acceptor (A)-site, the P-site and the exit (E)-site [76]. The three sites are named after 
the function of the tRNA at that specific position. At the A-site the correct aminoacyl-
tRNA is accepted. At this site decoding of the mRNA takes place. In the P-site the 
tRNA with the polypeptide chain is located. The E-site is occupied by an empty tRNA 
prior to being released from the ribosome.   
Elongation begins when the initiator tRNA occupies the P-site in the ribosome and the 
A-site is ready to accept an aminoacyl-tRNA. The addition of one amino acid to the 
peptide chain is a three step process. First a ternary complex composed of eukaryotic 
elongation factor (eEF) 1A, GTP and aminoacyl-t-RNA (carrying the anticodon 
corresponding to the codon adjacent to the initiation codon) is positioned at the A-site 
Figure 5: The methionine-loaded initiator 
tRNA (L-shaped symbol) binds to GTP-
coupled eIF2, to yield the ternary complex. 
This complex then binds to the small (40S) 
ribosomal subunit, eIF3 and other initiation 
factors to form the 43S pre-initiation complex. 
The pre-initiation complex recognizes the 
mRNA by the binding of eIF3 to the eIF4G 
subunit of the cap-binding complex. In addition 
to eIF4G, the cap-binding complex contains 
eIF4E, which directly binds to the cap, and 
eIF4A, an RNA helicase that unwinds 
secondary structure during the subsequent step 
of scanning. eIF4G also contacts the poly(A)-
binding protein (PABP) and this interaction is 
thought to circularize the mRNA. The 43S pre-
initiation complex scans the mRNA in a 5' to 3’ 
direction until it identifies the initiator codon 
AUG. Scanning is assisted by the factors eIF1 
and eIF1A. Stable binding of the 43S pre-
initiation complex to the AUG codon yields the 
48S initiation complex. Subsequent joining of 
the large (60S) ribosomal subunit results in the 
formation of the 80S initiation complex. Both 
AUG recognition and joining of the large 
ribosomal subunit trigger GTP hydrolysis on 
eIF2 and eIF5B, respectively. Subsequently, 
the 80S complex is competent to catalyze the 
formation of the first peptide bond. Pi, 
inorganic phosphate. [2] 
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of the ribosome. Second, the formation of the peptide bond is catalyzed through 
eEF1A-mediated hydrolysis of GTP to guanosine di-phosphate (GDP) [77, 78]. Third, 
once the bond is formed the mRNA is shifted by one codon by the eEF2 translocase 
[79]. This shifts the tRNA with its attached peptide to the P-site and opens the A site 
for the arrival of a new aminoacyl-tRNA. The deacetylated empty t-RNA is shifted to 
the E-site. This process is repeated until a stop codon is recognized and translation is 
terminated.  
3.6.2 Termination 
Two classes of eukaryotic polypeptide release factors govern the translation 
termination: class-1 (eRF1) and class-2 (eRF3) [80, 81]. If a stop codon lies in the A-
site it is recognized by eRF1, and as a result eRF3, a GTPase bound to eRF1, 
hydrolyses GTP to GDP and the peptidyl-tRNA ester bond is cleaved, which causes 
the release of the newly formed peptide [82].  
3.6.3 Recycling 
Once the protein is released from the ribosome, the mRNA-tRNA-ribosome complex 
needs to be disassembled. In prokaryotes this process was first described already in 
1972 but in eukaryotes only recently a model for ribosomal recycling has been 
suggested [83, 84]. In eukaryotes, recycling starts with the binding of eIF3 promoting 
release of the large (60S) ribosomal subunit [84]. In this model the 40S-mRNA-tRNA 
complex needs to be disassembled and this is facilitated through both the action of 
eIF1 ejecting deacylated tRNA from the P-site of the ribosome, and the action of 
eIF3j releasing all small ribosomal subunits from the mRNA [84, 85]. 
3.7 Cytoplasmic poly(A) binding proteins (PABPs) 
Poly(A) binding proteins (PABPs) are a family of proteins characterized by their 
ability to bind the poly(A) RNAs via their RNA-recognition motifs (RRM). PABPs 
are found in yeast, plants, and animals but not in prokaryotes. PABPs are divided into 
two groups: nuclear and cytoplasmic. The human cytoplasmic PABP family consists 
of four members: PABP1, testis PABP (tPABP), inducible PABP (iPABP), and 
PABP5. Generally, PABPs consist of four non-identical RRMs connected to a 
carboxyl-terminal domain by a linker region that is rich in prolines and methionine 
residues [86]. In Figure 6 the overall structure of the different members of the PABP 
family is depicted.  
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Figure 6: General structure of human poly(A)-binding protein (PABP) family members. P = proline. [87] 
 
RRM1 und RRM2 bind poly(A) residues with high affinity, which leads to a globular 
structure that enables the simultaneous binding with other proteins [88]. PABPC1 also 
bind poly uracil and poly guanine although with lower affinity and does not bind poly 
cytosine [89]. At least 12 nucleotides are required in vitro for high affinity binding of 
RNA [90]. PABPs also interact with other proteins through its PABC domain. For 
example, the PABC domain mediates interaction with proteins that contain the PAM2 
motif [91]. This motif has the consensus xxФx(P/V)xAxxFxP, where Ф is a 
hydrophobic residue [92]. In Table 1 a number of known PAM2 motif-containing 
PABP interactors are shown. 
 
Name Position of first amino acid Amino acid sequence 
Paip1 123 SKLSVNAPEFYPSGYSS 
Paip2 109 SNLNPNAKEFVPGVKYG 
Ataxin-2 912 STLNPNAKEFNPRSFSQ 
eRF3 50 RQLNVNAKPFVPNVHAA 
eRF3 59 FVPNVHAAEFVPSFLRG 
Tob1 265 SALSPNAKEFIFPNMQG 
PAN3 84 KTPNPTASEFIPKGGST 
NF-X1 11 FKFNTDAAEFIPQEKKN 
 
Table 1: PAM2 sequence of several known PABP interactors highlighting the most conserved amino acids is shown. Paip, 
PABP-interacting protein; Tob, transducer of Erb; PAN, poly(A)-specific nuclease; NF, nuclear factor. (adapted from [92]) 
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3.7.1 PABP1 
Alternative names are PAP1, PAB1, PAB, or PABC1. Its molecular weight is 70 000 
Da. It is the most extensively studied member of the family. It is predominantly 
cytoplasmic, but can also shuttle to the nucleus [93, 94]. PABP1 functions 
synergistically with the eIF4F initiation complex to promote translation initiation [95]. 
It has been proposed that PABP also plays a role in ribosomal recycling through its 
interaction with the eRF3 [9]. Furthermore, PABP1 may also be important in mRNA 
decay by influencing the deadenylation dependent decapping pathway and exosome-
mediated 3’-5’ degradation [96]. A role for PABP in NMD and translation termination 
has also been proposed [97]. Just recently, PABP was found to interact with the 
C-terminus of GW182, a core component of the micro RNA-loaded RNA-induced 
silencing complex (miRISC), allowing docking of the deadenylase complex [98].   
3.7.2 Testis PABP 
Alternative name is PABPC3. Its mRNA is abundantly expressed in testis and can be 
detected in specific types of male germ cells suggesting a function in spermatogenesis 
[99]. It is homologous to PABP1 keeping the same overall structure with reduced 
affinity of its RRMs to RNA [100]. The homology to PABP1 suggests a role of 
tPABP in mRNA translation and stability but such a function has not yet been proven 
experimentally. 
3.7.3 Inducible PABP 
Alternative names are PABPC4 or activated-platelet protein (APP) 1. Similar to 
PABP1, iPABP is ubiquitously expressed in all tissues but at much higher levels in 
heart and skeletal muscle tissue than PABP [101]. The nomenclature refers to the 
proteins low level expression in resting T cells and platelets and rapid upregulation  
following T cell or platelet activation [101], [102]. Even though iPABP is closely 
related to PABP1 considering overall structure, subcellular localization, and tissue 
expression pattern no function for iPABP in translation or stability has been described 
yet.  
3.7.4 PABP5 
Alternative name is PABPC5. It is expressed in different kind of tissues such as adult 
brain, heart, liver, muscle, kidney and ovary, as well as fetal brain [103]. PABP5 lacks 
Introduction Protein translation  
 28 
the PABC domain and the linker region. No function has yet been attributed to 
PABP5.  
 29 
Hypoxia 
3.8 Introduction 
In aerobic metabolism, energy that is stored in the form of ATP is mainly produced 
through a process termed oxidative phosphorylation. In this process, electrons are 
transferred through consecutive cytochromes to produce a proton gradient that is used 
to produce ATP. The final acceptor of the transferred electrons is oxygen. A constant 
oxygen supply is crucial for the maintenance of an adequate energy metabolism since 
incomplete transfer of electrons onto oxygen may lead to the production of harmful 
reactive oxygen species (ROS). Oxygen is distributed through the circulatory system 
via hemoglobin in the erythrocytes [104, 105]. To ensure sufficient oxygen transport 
to body tissues under low oxygen conditions such as at high altitude the body 
developed sophisticated physiological and molecular adaptation processes. In 1860, 
Viault observed an increase in red blood cell count at hight altitude [106]. In 1953, 
Allan Erslev discovered a humoral factor responsible for the increase in red blood cell 
production known today as erythropoietin (EPO) [107]. A major breakthrough in 
understanding the molecular mechanism behind Epo production came in 1991 when 
Wang and Semenza discovered the hypoxia inducible factor (HIF) to be responsible 
for the induced expression of the Epo gene during hypoxia through binding to a 
specific hypoxia-response element (HRE) in the 3’ flanking sequence of the EPO 
gene [108]. HIF was originally found to be involved in regulation of EPO gene 
expression under hypoxic condition. However, since 1992 dozens of HIF-target genes 
were discovered many of them being involved in facilitating oxygen delivery and 
cellular adaptation to hypoxia by inducing multiple biological processes involved in 
oxygen-homeostasis, glucose-energy-metabolism, angiogenesis, metal transport and 
growth [109].  
3.9 Hypoxia-inducible factor (HIF) 
3.9.1 Expression and Composition 
HIF is a heterodimeric protein complex consisting of an O2-regulated constitutively 
expressed HIF-α subunit and an oxygen insensitive constitutively expressed HIF-β 
subunit. HIF-β is also known as aryl hydrocarbon receptor nuclear translocator 
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(ARNT), due to the observation that it dimerizes with the aryl hydrocarbon receptor 
(AhR) upon activation through binding of aryl hydrocarbons such as dioxin [110]. 
Both α and β subunits are members of the basic helix-loop-helix Per/Arnt/Sim 
(bHLH-PAS) transcription factor family [111]. For mammals, three isoforms of 
HIF-α are known: HIF-1α, HIF-2α (also known as endothelial PAS domain protein 
(EPAS) 1 or HIF-1α like factor (HLF)) and HIF-3α. In addition, three ARNT variants 
exist: ARNT, ARNT2 and ARNT3 [112, 113]. HIF-1α does not strictly associate with 
HIF-1β but can also dimerize with ARNT2 and ARNT3 [112, 113]. HIF-1α is 
ubiquitously expressed in all tissues and organs whereas HIF-2α and HIF-3α are more 
tissue-specific. HIF-2α has originally been described to be expressed primarily within 
vascular endothelial cells but later found to occur in fibroblast and epithelial cell lines 
as well [114, 115]. HIF-3α is primarily expressed within the kidney [116]. HIF-α 
protein consists of an N-terminal bHLH domain, that is necessary for DNA binding, 
and a PAS domain that is responsible for dimerization with ARNT [117]. 
Additionally, two transactivation domains (TADs) are found within the HIF-1α and -
2α protein. Of those, the C-terminal domain is responsible for the recruitment of 
transcriptional co-activators crucial for target gene expression [117]. Furthermore, 
HIF-α contains two domains that explicitly trigger the normoxic degradation of the 
protein termed oxygen-dependent degradation (ODD) domain [118]. A nuclear 
localization signal (NLS) can also be found in the protein [119, 120]. In Figure 7 the 
overall structures of HIF-α and –β is summarized. 
 
 Figure 7: Schematic representation of HIF family member protein domains. [121]  
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3.9.2 Regulation  
HIF is a central transcription factor that can control dozens of target genes. Clearly, 
HIF regulation is of crucial importance for cellular adaptations to periods of oxygen 
deprivation. Many cancers that are associated with the von Hippel-Lindau syndrome 
such as renal cell carcinoma are highly vascularized and expressed high levels of 
angiongenic factors such as vascular endothelial growth factor (VEGF) [122, 123]. 
This phenotype is also due to the fact that HIF is constantly active in these cancers 
since the HIF-α subunit remains stable due to the mal-functioning of the VHL protein, 
a substrate recognition component of an E3 ubiquitin ligase complex [124]. To ensure 
that HIF is not active under normal physiological conditions but rapidly activated 
under low oxygen conditions the body developed several levels of regulation most 
importantly post translational but also at the transcriptional level.     
3.9.2.1 Oxygen-dependent regulation 
3.9.2.1.1 Stability 
HIF-α and HIF-β transcripts and proteins are, in cultured cells at least, continuously 
synthesized independently of oxygen but only HIF-α proteins undergo oxygen-
regulated degradation [3]. Under normoxic conditions, two prolines (HIF-1α: 402 and 
564) within the ODD domain of the human HIF-α protein are hydroxylated by 
specific HIF prolyl-4-hydroxylases (PHDs) which enables the binding of pVHL [3]. 
HIF-α is ubiquitinated and subsequently targeted to the 26S proteasome for 
degradation [4, 5]. Under hypoxic conditions, the prolyl hydroxylation reaction is 
inhibited, which impedes the interaction of pVHL with HIF-α and results in HIF-α 
accumulation in the nucleus and dimerization with HIF-β [119, 125-127]. 
3.9.2.1.2 Transactivation activity 
In addition to prolyl hydroxylation, HIF-α is hydroxylated in oxygenated cells at a 
specific asparagine residue (HIF-1α: Asn803) by another hydroxylase termed factor 
inhibiting HIF (FIH) [128, 129]. The nature of this hydroxylation is not to cause 
HIF-a degradation but rather to block the interaction of HIF with the coactivators 
p300 and CBP [130]. Like PHDs, FIH is inhibited under hypoxia due to limited 
molecular oxygen leading to an active transactivation site. In Figure 8 a schematic 
overview on the oxygen-dependent regulation of HIF is given. 
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Figure 8: Oxygen-dependent regulation of hypoxia-inducible factor (HIF). (a) Under normoxic conditions, PHDs constitutively 
hydroxylate HIF-α on specific prolyl residues, and FIH constitutively hydroxylates HIF-α on a specific asparaginyl residue. 
Asparaginyl hydroxylation blocks the interaction between the transcriptional activation domain of HIF-α and the transcriptional 
co activator CBP/p300. Prolyl hydroxylation allows recognition by the VHL, a component of an E3 ubiquitin ligase complex that 
targets HIF-α for degradation by the proteasome. (b) Under hypoxic conditions, inhibition of prolyl hydroxylation promotes 
stabilization of HIF-α, which allows dimerization with HIF-β. Inhibition of asparaginyl hydroxylation unmasks the 
transcriptional activity of HIF-α, which allows binding of CBP/p300. [131] 
 
3.9.2.2 Oxygen-independent regulation 
In addition to the oxygen-dependent posttranslational regulation of HIF-α, a number 
of other mechanisms contribute to the downregulation of HIF activity or HIF protein 
levels. For example, the CBP/p300-interacting transactivators with glutamic acid (E) 
and aspartic acid (D)-rich tail (CITED) 2 inhibits HIF transactivation activity by 
blocking the HIF-1α–p300 interaction [132]. Another negative regulator of HIF is the 
acetyltransferase ARD1, a HIF-1 interactor that acetylates HIF at lysine 532 in the 
HIF-1α ODD domain. ARD1 enhances the HIF-1α-VHL interaction and leads to an 
increase in VHL mediated ubiquitination and subsequent proteasomal degradation of 
HIF [133].  
Besides post-translation events, HIF-α transcription or translation can be considered 
as another level of regulation. For example, it was observed that stimulation of cells 
with a variety of growth factors or cytokines induces the expression of HIF-1α under 
normoxic condition which, in turn, resulted in the expression of several HIF-target 
genes [134-136]. These activations involve mainly the mammalian target of 
rapamycin (mTOR) and mitogen-activated protein kinase (MAPK) signaling 
pathways. For instance, overexpression of the human epidermal growth factor (Her) 2 
in mouse 3T3 cells or hergulin stimulation of human MCF-7 cells resulted in 
increased HIF-1α protein translation and VEGF mRNA expression [137]. This 
increase was dependent upon activity of PI3K, AKT, and FRAPS [137]. A report 
Introduction Hypoxia  
 33 
from 1999 shows that Interleukin (IL) 1α and Tumor necrosis factor (TNF) α can 
increase HIF expression and normoxic DNA-binding activity [138, 139]. 
Furthermore, it has been demonstrated that the promyelocytic leukaemia (PML) tumor 
suppressor inhibits HIF-1α translation through repression of the mammalian target of 
ramamycin (mTOR) function [140]. The MAPK pathway may also be involved in 
regulation of HIF activity. For example, p42/p44 MAPK phosphorylates HIF-1α in 
vivo promoting the transcriptional activity of HIF-1α [141]. Also, hypoxia-activated 
GTPase Rac1 induces p38 MAPK activity, leading to HIF-1α phosphorylation and 
increased TAD function [142]. Interestingly, also a natural antisense transcript that is 
complementary to the 3′-UTR of HIF-1α mRNA exists that regulates the expression 
of HIF-1α on the mRNA level and is found to be overexpressed in nonpapillary 
kidney cancers [143]. The inhibitory PAS domain protein (IPAS), an alternative splice 
variant of HIF-3α, acts as a dominant negative transcription factor that represses the 
HIF-α activity [144].  
. 
3.10 The HIF prolyl-4-hydroxylases   
3.10.1 Discovery  
In 2001, two groups simultaneously discovered that oxygen-dependent hydroxylation 
of two prolines (402 and 564) in the ODD domain of human HIF-1α triggers the 
binding of pVHL to the protein [145, 146]. A few months later the enzymes 
catalyzing the hydroxylation reaction were identified [6, 147]. Epstein and colleagues 
revealed egg-laying abnormal (EGL) 9 to be the HIF prolyl hydroxylase in 
Caenorhabditis elegans and found three PHD genes that are homologous to EGL-9 in 
mouse and human. Originally termed PHD1, PHD2 and PHD3, other names have 
been used such as HIF prolyl hydroxylase (HPH) 3, HPH2, and HPH1 [147], or EGL 
nine homologue (EGLN) 2, EGLN1, and EGLN3 [148].  
3.10.2 Characterization 
3.10.2.1 PHD1 
The PHD1 gene is located on chromosome 19q13.2 and encodes a protein of 407 
amino acids giving it the size of 45 000 Da. Its mRNA is ubiquitously expressed 
within all tissues but especially abundant in testis [149]. Experiments using green 
fluorescence protein (GFP)-tagged PHD1 protein revealed subcellular localization 
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within the nucleus [150]. Another study using monoclonal PHD1 antibodies to target 
the endogenous protein showed predominant cytoplasmic staining for PHD1 [151]. 
Homozygous knock out of PHD1 facilitated HIF-1α-mediated cardio-protection in 
ischemia/reperfused (I/R) myocardium and protected against the development of 
colitits through reduced epithelial cell apoptosis and increased barrier function [152-
154]. 
3.10.2.2 PHD2 
The PHD2 gene is located on chromosome 1q42-43 and encodes a protein of 426 
amino acids giving it the size of 46 000 Da. Its mRNA is abundantly expressed in all 
tissues [149]. In normal tissue PHD2 is mainly expressed within the cytoplasm but 
increased nuclear PHD2 expression can be observed in less differentiated phenotypes 
of cancer cells [151, 155]. It has been postulated that PHD2 is the main regulator of 
HIF-1α [7]. PHD2 knock out embryos die between E12.5 and E14.5. Silencing PHD2 
in adult mice causes increased renal EPO production and polycythemia [156, 157]. 
3.10.2.3 PHD3 
The PHD3 gene is located on chromosome 14q13.1 and encodes a protein of 239 
amino acids giving it the size of 27 000 Da. Its mRNA is ubiquitously expressed 
within all tissues but especially abundant in heart and liver [149]. PHD3 is expressed 
in cytoplasm as well as in the nucleus [151]. PHD3 is also termed smooth muscle 
(SM) 20 since it was found to be upregulated in rat smooth muscle cells after growth-
factor stimulation [158]. Knock out of PHD3 in mice show reduced neuronal 
apoptosis, abnormal sympathoadrenal development, and reduced blood pressure 
[159]. 
3.10.3 Enzymatic activity 
3.10.3.1 Overview 
The PHDs belong to the superfamily of iron- and 2-oxoglutarate-dependent 
dioxygenases. Of the diatomic O2 substrate, PHDs use one oxygen atom to 
hydroxylate prolines and the second one to convert 2-oxoglutarate to CO2 and 
succinate. Fe2+ and ascorbate are cofactors in the reaction.  
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 Figure 9: The reaction catalyzed by the PHDs . [160] 
 
3.10.3.2 Oxygen 
With the discovery of the PHD’s in 2001 it was shown that the PHD enzymatic 
activity is highly sensitive to hypoxia [6]. In a study published in 2003 it was 
demonstrated that the Km values for oxygen for all three PHDs ranged between 
230-250 µM [161]. As this low affinity corresponded to a concentration slightly 
above the level of dissolved oxygen in air, it suggested PHDs to function as bona fide 
HIF oxygen sensors [161]. Interestingly, PHD2 and PHD3 are themselves HIF-1 
target genes. In 2006, Stiehl and colleagues suggested an autoregulatory mechanism 
by which increased PHD2 and PHD3 protein abundances compensate for the reduced 
oxygen availability in recurring or prolonged hypoxia to reset HIF sensory thresholds 
[162].  
3.10.3.3 Iron and ascorbate 
PHDs are non-heme Fe-binding dioxygenases. Iron chelators, such as 
desferrioxamine, can stabilize the HIF-1α/-2α proteins in normoxia and trigger the 
induction of the HIF target gene presumably via the inhibition of PHD activity [163, 
164]. It has already been known since the 1950s that cobalt chloride could be used for 
the treatment of sickle cell anemia [165]. The discovery of the PHDs shed light on the 
mechanism by which cobalt chloride is beneficial for the treatment of anemia: Cobalt 
and other transition metal ions such as nickel and manganese might compete with iron 
for the active site in the HIF sensor, thereby mimicking hypoxia-inducing HIF target 
gene expression [166]. Ascorbate plays an important function in the hydroxylation 
activity of the PHDs since it protects the enyzme’s amino acid residues and/or active 
center iron from being oxidized [167]. In line with that finding, it has been shown that 
ascorbate is promoting PHD activity in cancer cells [168]. In another publication 
Nytko and colleagues showed that ascorbate is essential for PHD function in vitro 
[169]. 
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3.10.3.4  Citric acid cycle intermediates 
2-oxoglutarate is a key intermediate in the citric acid cycle and functions as 
cosubstrate for PHD-mediated hydroxylation. Fumarate hydratase (FH) and Succinate 
dehydrogenase (SDH) are enzymes of the citric acid cycle that catalyze the reduction 
of fumarate to L-malate and succinate to fumarate, respectively. I has been shown that 
germline mutations in FH can cause leiomyomas and renal cancer, whereas mutations 
in SDH may cause paragangliomas and phaeochromocytomas [170, 171]. 
Accumulation of these citric acid cycle intermediates is accompanied by the 
accumulation of the HIF-1α protein [172]. It has been suggested that loss-of-function 
of these enzymes causes the activation of the HIF-pathway by inhibiting PHDs since 
accumulation notably of succinate (i.e. in cases of SDH loss-of-function mutations) 
causes product inhibition of the PHDs. [173, 174].  
3.10.4 Substrate specificity 
All three PHDs hydroxylate the proline residue that is found within an LxxLAP motif 
(where x is any amino acid and P is the hydroxylacceptor proline) in vitro [175]. This 
motif is conserved in both hydroxylation sites and between different HIF isoforms. 
Surprisingly, mutation of any of the amino acids within the motifs revealed that only 
the proline is critical for the hydroxylation reaction [176]. Interestingly, it was 
demonstrated that a leucine, 10 residues C-terminal of both hydroxyprolines, is 
essential for VHL recognition [177]. In the last few years other proteins that are 
hydroxylated in the context of a LxxLAP motif have been described. For example, 
Kuznetsova and colleagues showed that RNA polymerase subunit B1 (Rpb1), the 
major subunit of the RNA polymerase II, is hydroxylated by PHDs (mainly PHD1) 
and targeted by pVHL [178]. A study performed in 2005 revealed 5000 different 
proteins containing one ore more LxxLAP motifs [179]. They found that the 
erythroid-specific aminolevulinate synthase (ALAS) 2 contains an LxxLAP motif and 
it has been shown that ALAS2 is hypoxically upregulated [180]. In 2006, Cummins 
and colleagues demonstrated that hypoxia increases both the expression and activity 
of IκB kinase (IKK) β, and site-directed mutagenesis of the proline residue (P191A) 
of the putative IKKβ hydroxylation site resulted in a loss of hypoxic inducibility 
[181]. However, evidence for hydroxylation of the proline residue is still missing. The 
iron regulatory protein (IRP) 2 has been suggested to be regulated by PHDs. For 
example, degradation of IRP2 is inhibited by hypoxia, desferrioxamine or DMOG 
Introduction Hypoxia  
 37 
treatment [182, 183] – the latter two compounds known to mimic low oxygen levels 
by potently inactivating HIF prolyl and asparaginyl hydroxylases. Furthermore, IRP2 
coimmunoprecipitates with VHL and promotes the ubiquitination and decay of 
transfected IRP2 [184]. However, no LxxLAP has been found in IRP2. The activating 
transcription factor (ATF) 4 was found to interact with PHD3 and ATF4 protein 
stability were increased by hypoxia or PHD inhibition. In addition, siRNA-mediated 
down-regulation of PHD3 resulted in increased ATF4 protein levels [185]. However, 
if ATF4 is a novel PHD3 hydroxylation substrate remains unknown. 
3.10.5 PHD2 interactors 
In the last few years a number of novel PHD interactors have been described. This 
includes novel PHD hydroxylation targets but also proteins that regulate PHD 
function through modulating enzymatic activity or stability. For example, it has been 
shown by mass spectrometry analysis that the RING finger E3 ubiquitin ligase seven 
in absentia homolog (SIAH) 2 interacts with PHDs with the following tight-weak 
relative ranking: PHD3 > PHD1 >> PHD2 [186]. The same work documented PHD3 
stability to be regulated by SIAH2 via the targeting of PHD3 for proteasomeal 
degradation [186]. FKBP38, a peptidyl-prolyl cis/trans isomerase (PPIase) interacts 
specifically with PHD2 where it functions as adaptor in mediating the interaction of 
PHD2 with the proteasome to initiate the degradation of PHD2 [187, 188]. Other 
proteins have been described as putative novel PHD targets. For example, siRNA-
mediated knock-down of PHD1 and PHD2 as well as treatment of cells with the PHD 
inhibitor DMOG resulted in NFkappaB induction [181]. Furthermore, overexpression 
of PHD1 decreased cytokine-stimulated NFκB reporter activity [181]. This finding 
suggested that IKKB might be a novel PHD hydroxylation target. Another protein 
reported to be hydroxylated in a PHD-dependent manner is Rpb1 [189]. Rpb1 can 
bind PHD1 and PHD2 and PHD1 (but not PHD2 and PHD3) was necessary for 
oxidative-stress-induced P1465 hydroxylation [178, 189]. 
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Abstract 
 
The hypoxia-inducible transcription factor (HIF) is a key component of the cellular 
adaptation mechanisms to hypoxic conditions. HIFα subunits are degraded by prolyl-
4-hydroxylase domain (PHD) enzyme-dependent prolyl-4-hydroxylation of LxxLAP 
motifs that confer oxygen-dependent proteolytic degradation. Interestingly, only three 
non-HIFα proteins contain two conserved LxxLAP motifs, including the putative 
RNA helicase with a zinc finger domain HELZ. However, HELZ proteolytic 
regulation was found to be oxygen-independent, supporting the notion that a LxxLAP 
sequence motif alone is not sufficient for oxygen-dependent protein destruction. Since 
biochemical pathways involving RNA often require RNA helicases to modulate RNA 
structure and activity, we used luciferase reporter gene constructs and metabolic 
labeling to demonstrate that HELZ overexpression activates global protein translation 
whereas RNA-interference mediated HELZ suppression had the opposite effect. 
Although HELZ interacted with the poly(A)-binding protein (PABP) via its PAM2 
motif, PABP was dispensable for HELZ function in protein translation. Importantly, 
downregulation of HELZ reduced translational initiation, resulting in the disassembly 
of polysomes, in a reduction of cell proliferation and hypophosphorylation of 
ribosomal protein S6.  
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Introduction 
 
RNA helicases use ATP to modulate the structure of RNA, thereby altering the 
biologic activity of the RNA molecule or regulating access by other proteins. 
Virtually all biochemical processes involving RNA, including transcription, splicing, 
transport, translation, decay and ribosome biogenesis, employ helicases [1, 2]. The 
putative RNA helicase with a zinc finger domain HELZ belongs to the Upf1-like 
family of the superfamily I class of helicases [3, 4]. Members of this family have 
previously been implicated in mRNA processing [5, 6]. Tagged-HELZ has been 
shown to co-immunoprecipitate with co-transfected histone methyltransferases Smyd2 
and Smyd3 and a functional role as adaptor molecule to RNA polymerase II has been 
suggested [7, 8]. However, the function of HELZ, especially in RNA metabolism, 
remained incompletely understood.  
 We identified two conserved LxxLAP motifs in the HELZ protein sequence 
which are known to be hydroxylated within the α-subunit of hypoxia-inducible 
transcription factors (HIFs). Transcriptional activation of oxygen-regulated genes by 
heterodimeric HIFs is a crucial step in the adaptation of mammalian cells to low 
oxygen [9, 10]. HIFα subunits are constitutively expressed but the protein stability is 
regulated by oxygen-dependent hydroxylation of specific prolyl residues located 
within the LxxLAP sequence by members of the prolyl-4-hydroxylase domain (PHD) 
enzyme family. Prolyl-4-hydroxylation is necessary for the interaction with the von 
Hippel-Lindau tumor suppressor protein (pVHL) that mediates HIFα degradation [11, 
12, 13, 14, 15]. We report here that HELZ is oxygen-independently regulated, 
confirming that the sole presence of even two conserved LxxLAP motifs does not 
allow the prediction of oxygen-dependent regulation of protein stability.  
 Protein synthesis is regulated at various levels, but the limiting step is 
translational initiation. During this step, the 40S small ribosomal subunit is recruited 
to the mRNA 5’ end, scans towards a start codon and starts polypeptide synthesis by 
assembling the complete ribosome [16, 17]. Control of translation is often achieved 
by modulation of eukaryotic initiation factors (eIFs). The 5’ cap mRNA structure is 
bound by eIF4E, while eIF4G interacts with the poly(A)-binding protein (PABP) that 
associates with the 3’ poly(A) tail of eukaryotic mRNAs. eIF4A is a DEAD box RNA 
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helicase that resolves mRNA secondary structures and eIF4B harbors two RNA-
binding domains interacting with mRNA and the 18S small ribosomal subunit [18]. 
Whereas translational initiation is suppressed by association of 4E-binding proteins to 
eIF4E, translation is activated following 40S ribosomal protein S6 kinase (S6K)-
mediated phosphorylation of eIF4B that is then recruited to the initiation complex and 
enhances RNA helicase activity of eIF4A. Central in the regulation of the activity of 
these translation initiation factors is the mammalian target of rapamycin (mTOR) 
signal transduction pathway that integrates information on nutrients, energy, stress, 
hormones and mitogens with modulation of protein synthesis [19].  
 Here, we provide evidence that HELZ is involved in global protein translation. 
Mechanistically, HELZ downregulation resulted in S6 hypophosphorylation and 
dissociation of polysomes, suppressing cell proliferation.  
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Results 
 
The putative RNA helicase HELZ contains two conserved LxxLAP motifs 
A comprehensive in silico screen for proteins containing two LxxLAP motifs, like the 
HIFα subunits, revealed several candidate LxxLAP containing proteins in the human 
genome. To narrow down this list of proteins we further evaluated conservation across 
several species, which is generally considered suggestive for functionality of a 
sequence motif. Surprisingly, besides HIF-1α and HIF-2α only three additional such 
proteins were identified: HELZ, CCR4-NOT transcription complex (CNOT1) and 
faciogenital dysplasia protein (FGD1) (Supporting Table 1). Whereas CNOT1 is 
important for regulation of mRNA synthesis and decay [20], FGD1 encodes a guanine 
nucleotide exchange factor, activating the GTPase Cdc42 that is important for 
regulation of membrane trafficking [21]. However, none of these proteins have 
previously been reported to be oxygen-dependently regulated.  
In our further studies, we concentrated on HELZ (accession number 
NP_055692.2), because coincidentally the same protein has been identified in a 
previously performed yeast two-hybrid screen for PHD2 interactors [22], suggesting 
that the two conserved LxxLAP motifs might be of functional relevance for 
interaction with the PHD oxygen sensors and probably oxygen-dependent regulation 
of HELZ protein stability and/or function. HELZ belongs to the superfamily I class of 
RNA helicases and contains a N-terminal C3H1-type zinc finger as well as typical 
helicase motifs including an ATP-binding domain (Walker A) important for helicase 
activity, a DEAA and a PAM2 motif, known to be required for interaction with the 
poly(A) binding protein (PABP) (Figure 1A). Both the N-terminal LxxLAP sequence 
that is part of the PAM2 motif, as well as the C-terminal LxxLAP motif are well 
conserved in mammals (Figure 1B upper and lower panel, respectively). The 
N-terminal LxxLAP motif is conserved to lower vertebrates like teleosts, whereas the 
C-terminal LxxLAP sequence is present only in placental mammals.  
 
HELZ protein abundance is oxygen-independently regulated 
To analyze whether the LxxLAP sequences of HELZ might have similar proteolysis 
regulating function as in HIFα subunits, we cultured human embryonic kidney 
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HEK293 cells for different time periods under normoxic or hypoxic conditions and 
investigated HELZ protein abundance by immunoblotting (Figure 2A). However, 
whereas HIF-1α protein levels were hypoxically induced as expected, HELZ protein 
expression was not significantly affected and variations are probably due to 
difficulties in detecting the predicted 219 kDa protein by immunoblotting. Also the 
pan-PHD inhibitor dimethyloxalylglycine (DMOG) did not affect HELZ protein 
levels (data not shown). Anti-HELZ antibody specificity was verified by RNA 
interference-mediated HELZ knock-down in HEK293 cells (stable clone 4-10) as well 
as by using the Hodgkin’s lymphoma-derived cell line DEV that contains a 3-
megabase homozygous deletion at 17q24.1-24.2, which includes, amongst others, 
HELZ [23]. The cell line L428 is also derived from an Hodgkin’s lymphoma, but 
wild-type for HELZ, and served as positive control (Figure 2A).  
 HELZ mRNA levels were determined by RT-qPCR and although showing 
some variations were not significantly regulated under hypoxic conditions (Figure 2B, 
left panel). Hypoxic PHD2 mRNA induction served as positive control (Figure 2B, 
right panel). Organ-specific expression of HELZ in vivo has not been reported so far. 
In the mouse, HELZ mRNA levels varied between different tissues with highest levels 
in testis and brain and lowest in spleen and uterus (Figure 2C). Mice treated for 4 
hours with an inspiratory gas mixture containing 0.1% carbon monoxide, resulting in 
acute tissue hypoxia, displayed no significant variations in HELZ mRNA levels, 
whereas other HIF target genes have been found to be strongly induced in these tissue 
samples [24, 25]. Finally, HELZ subcellular localization was analyzed by confocal 
immunofluorescence microscopy and remained mainly cytoplasmatic with enhanced 
perinuclear staining, independent of oxygenation and PHD function (Figure 2D, upper 
panel). On the other hand, HIF-1α was almost undetectable under normoxic 
conditions and accumulated in the nucleus under hypoxic and PHD inhibiting 
conditions (Figure 2D, lower panel).  
 It has been shown that the HELZ interactor SMYD3 changes subcellular 
localization during cell cycle progression and several RNA helicases have been 
reported to shuttle between nucleus and cytoplasm [8, 26, 27] Thus, we synchronized 
the cell cycle of the human hepatoma cell line HuH-7 and examined HELZ 
subcellular localization during cell cycle progression by indirect immunofluorescence 
(Supporting Figure S1). However, HELZ subcellular localization was not altered 
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during cell cycle progression, remaining mainly in the cytoplasm. In summary, these 
data suggest that the two LxxLAP motifs of HELZ might have either oxygen-
independent functions, or oxygen-dependent functions that are not involved in 
proteolytic regulation like in the case of HIFα subunits, or no function at all. 
However, PHD-dependent modification of HELZ might still regulate HELZ 
function(s) other than protein abundance. 
 
HELZ interacts with the poly(A)-binding protein via its PAM2 motif 
The 3’ poly(A) tail of eukaryotic mRNAs is bound by PABP that interacts with 
eIF4G, a subunit of the multiprotein initiation complex that binds to the 5’ cap 
structure thereby regulating the initiation of translation. The PAM2 motif has 
originally been identified in the PABP interacting proteins Paip1 and Paip2 which 
regulate the activity of PABP [28]. The PAM2 motif is highly conserved in HELZ and 
overlaps with the N-terminal LxxLAP motif (Figure 1B). Therefore, we analyzed 
whether HELZ is able to interact with PABP by performing pull-down assays using 
HeLa cell lysates and GST-tagged HELZ fragments. As shown in Figure 3A, the 
PAM2 motif-containing GST-HELZ1023-1199 fragment interacted with PABP. GST-
Paip2106-127 and GST alone served as positive and negative controls, respectively. 
Equal input was controlled by Coomassie staining (data not shown). PABP from 
hypoxic HeLa cell extracts also associated with recombinant GST-HELZ1023-1199 
(Figure 3B) suggesting that the PABP:HELZ interaction was proline hydroxylation 
independent. Vice-versa, GST-PABP554-636 incubated with HEK293 cell lysates 
interacted with endogenous HELZ (Figure 3C).  
 The phenylalanine residue in the PAM2 motif of Paip1 and Paip2 is known to 
be critical for PABP binding [29]. Mutation of the corresponding phenylalanine in 
HELZ (F1107A) abrogated association with PABP, whereas mutation of the proline 
residue within the N-terminal LxxLAP sequence (P1105A) had no effect (Figure 3D). 
GST and GST-HELZ1727-1942 served as negative controls. Furthermore, the HELZ 
PAM2 motif overlaps with the eIF4E-binding signature YxxxxLΦ (x designates any 
amino acid and Φ a hydrophobic residue) [30] and we therefore tested, whether HELZ 
can interact with eIF4E. Wild-type PAM2 motif-containing HELZ fragments also 
interacted with eIF4E, but probably indirectly via binding to PABP since the 
Manuscript I  Results 
 45 
interaction was abrogated when the phenylalanine residue critical for PABP binding 
was mutated (F1107A) (Supporting Figure S2).  
 
HELZ is involved in global protein translation 
The identification of HELZ as a novel PABP-interacting protein suggested a role of 
HELZ in protein translation. Therefore, we co-transfected HeLa cells with V5-tagged 
HELZ together with a SV40-driven renilla luciferase reporter gene construct. 
Exogenous overexpression of increasing amounts of HELZ induced relative luciferase 
activities in a dose-dependent manner (Figure 4A). To investigate whether enhanced 
luciferase activities were due to upregulation of mRNA levels, we performed RT-
qPCR analysis. However, V5-HELZ expression did not influence renilla luciferase 
mRNA levels (Figure 4B). These effects were promoter-independent as the same 
regulation was observed with thymidine kinase (TK) and cytomegalovirus (CMV) 
driven reporter plasmids (data not shown). Vice versa, siRNA-mediated suppression 
of endogenous HELZ expression reduced luciferase activities (Figure 4C, upper 
panel). The HELZ siRNA oligonucleotides #9 and #11 efficiently down-regulated 
HELZ expression as verified by immunoblotting, whereas #12 was ineffective and 
used as control (Figure 4C, lower panel). Taken together, these data suggest that 
HELZ positively regulates reporter gene translation rather than transcription or 
mRNA stability. 
 To further investigate the role of HELZ on in cellulo protein translation, we 
performed [35S]-methionine incorporation assays. Global translation was significantly 
induced by exogenous HELZ expression (Figure 5A, left panel), confirming the 
function of HELZ in protein translation. Surprisingly, mutation of the phenylalanine 
residue critical for PABP association within the PAM2 motif of HELZ did not 
influence HELZ-dependent stimulation of translation (Figure 5A, left panel). 
Expression of the indicated constructs was controlled by immunoblotting (Figure 5A, 
right panel).  
 To further elucidate the mechanism of HELZ function in translation we 
performed additional mutagenesis studies (schematically depicted in Figure 5B). 
Whereas ATP-binding and ATP hydrolysis motifs have previously been demonstrated 
to be crucial for eIF4A helicase function [31], mutation of the corresponding residues 
in HELZ (GNT, DQAA and NEAA) resulted in maintained stimulatory effects on 
protein translation (Figure 5B, left panel). Moreover, neither proline mutations in the 
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PAM2 motif nor in the C-terminal LxxLAP motif significantly influenced the positive 
effect of HELZ on translation (Figure 5B, left panel). Exogenous expression of V5-
tagged HELZ constructs was controlled by immunobloting (Figure 5B, right panel). In 
addition, siRNA-mediated suppression of PABP did not influence the stimulatory 
effect of HELZ on global protein translation, supporting the notion that HELZ 
function is PABP independent (Figure 5C, left panel). Expression of the transfected 
vectors and PABP knock-down efficiencies were controlled by immunoblotting 
(Figure 5C, right panel).  
 
HELZ promotes cell proliferation and is involved in ribosomal protein S6 
phosphorylation 
Regulation of protein translation impacts cell growth and proliferation. Consistent 
with a reduction in global protein translation, proliferation of HeLa cells was reduced 
by siRNA-mediated HELZ suppression (Fig. 6A). Cell viability, as assessed by 
Trypan blue staining, was not affected in siRNA-silenced cells (data not shown), 
suggesting that HELZ modulates cell proliferation rather than cell death.  
 Cellular translation requires a multitude of resources and the mammalian 
target of rapamycin (mTOR) signaling pathway functions as pivotal integrator [19]. 
Thus, we analyzed components of the mTOR pathway in HELZ-silenced cells and 
found a significant downregulation of phosphorylated ribosomal protein S6 (p-S6) 
compared to control cells (Fig. 6B). Total protein levels of S6 and S6 kinase (S6K), as 
well as AKT and PABP were not affected. Importantly, stable HELZ downregulation 
in the HEK293 clone 4-10 (previously described in Fig. 1A) resulted also in 
attenuation of S6 phosphorylation (Fig. 6C). Clone 4-6 showed a somewhat 
intermediate HELZ and p-S6 suppression and clone 4-14 served as control, 
demonstrating dose-dependent attenuation of S6 phosphorylation in an independent 
tissue culture model.  
 To determine at which step HELZ is involved in translational regulation, we 
analyzed polysome profiles from HELZ-silenced and control siRNA oligonucleotides 
transfected cells. HELZ downregulation resulted in dissociation of polysomes with a 
concomitant increase in the amount of 80S ribosomes and 60S subunits (Fig. 6D). 
Consistent with a mainly cytoplasmatic localization, these data suggest that HELZ 
functions in translational initiation.  
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Discussion 
 
Although the specific prolyl residues within the HIFα subunits hydroxylated by PHDs 
share the sequence LxxLAP, in vitro studies on hydroxylase activity using substrate 
mutations have indicated that very few residues outside the hydroxylated proline itself 
are critical for hydroxylation [32, 33]. Fragments encompassing the entire HIFα 
oxygen-dependent degradation (ODD) domain are much better PHD substrates than 
short 20 amino acid model peptide substrates [34, 35], suggesting that the enzyme-
substrate interaction requires multiple contacts. Indeed, crystal structure analysis 
suggested that the target proline is inserted into the hydroxylase active site while the 
rest of the unstructured ODD domain adopts an extended conformation around the 
enzyme [36, 37]. Nevertheless, also non-HIFα proteins have been proposed to be 
hydroxylated by PHDs within the context of an LxxLAP motif. PHD1 has been 
reported to hydroxylate Rpb1, the large subunit of the RNA polymerase II, as well as 
the IκB kinase-β (IKKβ), leading to hypoxic activation of NFκB [38, 39]. Our data 
indicate that conserved LxxLAP motifs can also be found within the PABP-
interacting motif PAM2, but the presence of this motif alone cannot be taken as 
prerequisite for oxygen-dependent regulation. Furthermore, also the only two other 
proteins harboring two conserved LxxLAP motifs CNOT1 and FGD1, have not been 
described in the context of oxygen-dependent regulation.  
Translational control is a crucial mechanism for a rapid response to physiological 
changes. Binding of PABP to the poly(A) tail of the mRNA is an important step in 
translation initiation, since it mediates the circularization of the mRNA through 
interaction of PABP with eIF4G, a member of the translation initiation complex [40]. 
Several other PABP binding partners, such as Paip1 and Paip2 have been described to 
associate through the PABP-interacting motif 2 (PAM2) [28, 41] and modulate PABP 
function [42, 43]. A bioinformatic survey has identified, among others, HELZ as 
PAM2 motif containing protein [44] and our data confirm that HELZ interacts with 
the PAM2 motif with PABP. Surprisingly, mutation of the phenylalanine residue 
critical for PABP association within the PAM2 motif of HELZ and siRNA-mediated 
suppression of PABPC1 did not influence HELZ-dependent stimulation of translation, 
suggesting that the HELZ function in protein translation is independent of PABP. 
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However, we cannot rule out that other cytoplasmic PABPs or inducible PABP 
(iPABP) might compensate for PABPC1. Interestingly, it has been shown that the 
PABC1 interactor Tob also associate with iPABP [45] and we can not exclude that 
HELZ promotes its effect indirectly. Furthermore, PABP-independent regulatory 
mechanisms of translation initiation are known and HELZ function might be specific 
for such mRNAs [46]. In addition, the stimulatory function of the putative RNA 
helicase HELZ on global protein translation was independent of the motifs derived 
from known RNA helicases, suggesting that either RNA helicase activity is not 
required for function of HELZ in translation, HELZ is not a RNA helicase or contains 
additional helicase motifs as previously suggested by Czaplinski et al. [5].  
Ribosomal protein S6 is located within the 40S small ribosomal subunit and is 
essential for the translation of mRNAs encoding important components of the 
translation machinery, such as ribosomal proteins and elongation factors [47]. 
Phosphorylation of S6 is regulated by mTOR complex 1 (mTORC1) that activates S6 
kinase (S6K) as well as compensatory pathways involving AKT or MAPK. Although 
hypophosphorylation of S6 by HELZ downregulation was independent of total S6K 
levels, we cannot exclude that HELZ modulated S6K activity directly or alternatively 
by reducing the activity or expression of a S6K-specific phosphatase. It has been 
suggested that Type 1 phosphatases can dephosphorylate ribosomal protein S6 and 
interestingly in this regard, the mammalian alpha4 phosphoprotein, a regulator of the 
protein phosphatase 2, has recently been described to interact with PABP [48]. 
Clearly, further experiments are needed to reveal the mechanism by which HELZ 
promotes S6 phosphorylation.  
Human HELZ has alternatively been termed down-regulated in human cancers 
(DRHC). However, this was based on semi-quantitative RT-PCR analysis of HELZ 
expression in 95 tumor cell lines and the observation that exogenous HELZ 
expression inhibited proliferation and colony formation of hepatoma cells in vitro 
[49]. Contrary, the only functional HELZ data published so far suggest an adaptory 
role for HELZ linking the histone methyltransferase Smyd3 to RNA polymerase II, 
thereby transactivating oncogenes, homeobox genes and cell cycle regulators [8]. 
Smyd3 is up-regulated in colorectal and hepatocarcinoma cell lines and Smyd3 
overexpression elevated proliferation and colony-formation capacity in vitro, 
suggesting that HELZ functions rather as tumor promoting factor [8]. Although we 
did not analyse the role of HELZ using tumor formation assays, our findings that 
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HELZ functions as a positive factor in translation support the tumor promoting 
hypothesis suggested by Hamamoto et al. 
 In summary, we provide evidence that the presence of even two conserved 
LxxLAP sequence motifs is not indicative of oxygen-dependent proteolytic regulation 
and describe to our knowledge for the first time a functional role of HELZ in initiation 
of translation and ribosomal protein S6 phosphorylation.  
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Materials and methods 
 
Plasmids 
Unless otherwise indicated, cloning work was carried out using Gateway technology 
(Invitrogen, Basel, Switzerland) as described previously [22]. The HELZ1-1942 cDNA 
was obtained from Origene (LabForce, Nunningen, Switzerland) and cloned into 
pENTR4 (Invitrogen). pDONR-HELZ1727-1942 originated from the yeast two-hybrid 
screen as described previously [22]. Point mutations were generated by site-directed 
mutagenesis of pENTR4-HELZ1-1942 using the QuickChange site-directed 
mutagenesis kit following the manufacturer's instructions (Stratagene, Agilent 
Technologies, Basel, Switzerland). The HELZ fragment corresponding to amino acids 
1023 to 1199 was amplified by PCR from pENTR4-HELZ1-1942. The expression 
vectors pGEX-6P-1-Paip2106-127 and pcDNA3.1-Paip1 were kindly provided by K. 
Gehring and N. Sonenberg (McGill University, Montreal, Canada), respectively.  
 
Cell culture and transfections 
Human MCF-7 breast carcinoma, human HeLa cervical carcinoma and human 
embryonic kidney HEK293 cells were cultured in high-glucose Dulbecco’s modified 
Eagle’s medium (DMEM) (Sigma, Buchs, Switzerland) as described previously [50], 
and human hepatoma HuH-7 cells were cultured in RPMI-1640 [51]. For long-term 
hypoxia, cells were grown in a gas-controlled glove box (InvivO2 400, Ruskinn 
Technologies, Leeds, UK). Transfections were performed using polyethylenimine 
(Polysciences, Warrington, PA, USA) as described previously [25] or 
Lipofectamine2000 (Invitrogen).  
 
Normoxic and hypoxic mouse tissue samples 
Exposure of mice to an inspiratory gas mixture containing 0.1% carbon monoxide for 
4 hours resulted in a 50% functional anemia and has been described elsewhere [24].  
 
Immunoblotting 
Immunoblot analyses were performed as previously described [52]. Antibodies used 
were mouse monoclonal antibody (mAb) anti-HIF-1α (Transduction Laboratories, 
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BD Biosciences, Allschwil, Switzerland), mAb anti-HELZ (Abnova, LucernaChem, 
Luzern, Switzerland), mAb anti-β-actin (Sigma), rabbit polyclonal antibody (pAb) 
anti-SP1 (Santa Cruz Biotechnology, LabForce, Nunningen, Switzerland), pAb anti-
PABP (Abcam, LucernaChem), pAb anti-AKT, anti-S6K, anti-S6 and anti-pS6 (Cell 
Signaling, BioConcept, Allschwil, Switzerland).  
 
mRNA quantification 
Total cellular RNA was extracted as described previously [22]. First-strand cDNA 
synthesis was performed with 1-5 µg total RNA using reverse transcriptase (RT) and 
mRNA levels were measured by real-time quantitative (q) PCR using internal 
calibration standards and a SybrGreen qPCR reagent kit (Sigma) in combination with 
the MX3000P light cycler (Stratagene). To verify RNA integrity and equal input 
levels, ribosomal protein L28 or S12 mRNA was determined, and the data were 
expressed as ratios relative to L28 or S12 mRNA levels. 
 
Immunofluorescence microscopy 
Indirect immunofluorescence microscopy was performed as described previously 
[22]. For synchronization experiments, cells were growth-arrested in the G0/G1 phase 
by incubation with 5 µg/ml aphidicolin (Sigma) for 36 hours. Immunofluorescence 
staining was performed at times 0, 4, 8 and 12 hours after the withdrawal of 
aphidicolin. Cell cycle stage was determined by staining cells with propidium iodide 
and analyzed by flow cytometry (BD Biosciences).  
 
Protein expression and purification 
GST and GST fusion proteins were expressed in Escherichia coli BL21-AI by 
induction with 0.025% arabinose for 4 hours and affinity purified using glutathione-
sepharose beads (GSTrap FF; GE Healthcare, Dübendorf, Switzerland) according to 
the manufacturer's instructions.  
 
Pull-down assays 
HeLa cells were grown to 80% confluency and lysed in buffer A (20 mM Hepes/KOH 
(pH 7.4), 100 mM KCl, 0.1% NP-40, 0.5 mM EDTA, 10% (v/v) glycerol and protease 
inhibitors (complete EDTA-free, Roche Applied Science, Rotkreuz, Switzerland). 
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Recombinant GST or GST-HELZ fusion proteins (0.5 µg) were incubated with total 
HeLa cell extracts (2.5 mg) in the presence of glutathione-sepharose beads for 3 hours 
at 4°C. Beads were washed ten times in buffer A and bound proteins were eluted by 
incubation in SDS-PAGE loading buffer.  
 
Transient transfection and luciferase assay 
Cells were co-transfected with the indicated firefly luciferase reporter gene plasmids 
together with 40 ng pRLSV40 renilla luciferase reporter gene vector (Promega, 
Dübendorf, Switzerland) and luciferase activity was determined using the dual-
luciferase reporter assay system according to the manufacturer’s instructions 
(Promega).  
 
RNA interference 
Cells were transfected with either 100 nM siRNA (Invitrogen) or 50 nM siRNA 
(Dharmacon, Fisher Scientific, Wohlen, Switzerland) duplex oligonucleotides using 
Lipofectamine 2000 (Invitrogen). The following forward siRNA oligonucleotides 
(Invitrogen) were used:  
Control siRNA,   5’-GCUCCGGAGAACUACCAGAGUAUUA-3’;  
HELZ siRNA#2, 5′-UUCAGCUGCAUGCAGCAAAGCACUG-3′;  
HELZ siRNA#3, 5′-AUGAGGUGGUGUUUACCCAGGACUC-3′.  
The following forward siRNA oligonucleotides (Dharmacon) were used:  
HELZ siRNA#09,   5’-CGUGUAUAAAGUCGGGAUA-3’;  
HELZ siRNA#11,   5’-GCAGUUGAUCCUCGAAUUA-3’;  
HELZ siRNA#12,   5’-AAUCACAAGCAGCGAGGAA-3’;  
PABPC1 siRNA#5, 5’-CAUGUAAGGUGGUUUGUGA-3’;  
PABPC1 siRNA#8, 5’-UGGAUGAGAUGAACGGAAA-3’.  
The ON-TARGETplus siCONTROL non-targeting pool from Dharmacon was used as 
control. Expression vectors encoding shRNA sequences targeting HELZ driven by the 
U6 promoter in a pLKO.1-puro plasmid were purchased from Sigma.  
 
Metabolic labelling 
After transfection of cells with siRNA oligonucleotides or plasmids, cells were 
incubated for 2 hours in methionine-depleted medium supplemented with 10% (v/v) 
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dialyzed FCS. Cells were pulse-labeled with 20 µCi of [35S]-methionine for 1 hour. 
Finally, cells were washed twice in ice-cold PBS and lysed with buffer containing 10 
mM Hepes/KOH (pH 8.0), 1.5 mM MgCl2, 10 mM KCl and 0.5% NP-40 
supplemented with EDTA-free protease inhibitors for 15 minutes. Lysates were 
centrifuged for 15 minutes and protein concentrations determined. Total protein (10 
µg) was precipitated by 10% trichloroacetic acid, washed twice in ice-cold acetone 
and radioactivity was measured by scintillation counting.  
 
Polysomal profiles analysis 
HeLa cells were transfected with siRNA oligonucleotides and 48 hours later treated 
with 100 µg/ml cycloheximide for 15 min at 37°C. Cells were then washed with ice-
cold PBS and lysed by addition of 300 µl lysis buffer containing 10 mM Hepes/KOH 
(pH 7.5), 10 mM MgCl2, 50 mM KCl, 2 mM DTT, 0.5% NP-40 and 1% deoxycholate 
supplemented with EDTA-free protease inhibitors for 15 minutes. Lysates were 
centrifuged for 15 minutes at 12’000 x g. The supernatant was loaded onto a 7-50% 
sucrose density gradient containing 50 mM Tris-acetate (pH 7.4), 50 mM NH4Cl, 12 
mM MgCl2 and 1 mM DTT. The gradient was centrifuged at 39’000 rpm for 165 
minutes at 4°C (SW41 Beckman Coulter) and analyzed at 254 nm using a density 
gradient fractionator.  
 
Statistical analysis 
Where not otherwise indicated, results are presented as mean values ± standard error 
of the mean of at least n = 3 independent experiments. All statistical tests were 
performed and graphed using GraphPad Prism v4.0 software (*, P < 0.05; **, P < 
0.01).  
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Figure legends 
 
Figure 1 
Human HELZ protein sequence analysis 
(A) Schematic representation of the predicted human HELZ protein architecture. (B) 
Sequence alignment of the N-terminal LxxLAP motif that overlaps with the PAM2 
motif (upper panel) and C-terminal LxxLAP motif (lower panel) of the indicated 
species. The LxxLAP motif is depicted in red and strictly conserved residues are 
shown as white letters on black background.  
 
Figure 2 
Oxygen-independent regulation of HELZ 
(A) Immunoblot analysis of HEK293 cells cultured under normoxic or hypoxic 
conditions for the indicated time periods. The stable HELZ shRNA clone 4-10 and the 
Hodgkin’s lymphoma-derived cell line DEV containing a homozygous deletion on 
chromosome 17 served as controls for reduced and absent HELZ protein levels, 
respectively. The Hodgkin’s lymphoma derived cell line L428 served as positive 
control. (B) Transcript levels of HELZ were analyzed in HEK293 cells by RT-qPCR. 
Cells were exposed to hypoxia (0.2% O2) for up to 48 hours and PHD2 served as 
hypoxia-inducible control. (C) Total RNA was extracted from tissue samples of 
various organs from mice exposed to inspiratory air (0% FiCO) or 0.1% carbon 
monoxide (0.1% FiCO) for 4 hours and HELZ transcript levels were quantified by 
RT-qPCR and normalized to ribosomal protein S12 mRNA levels. (D) MCF-7 cells 
were cultured under 20% O2 or 0.2% O2 for 18 hours, fixed, and HELZ as well as 
HIF-1α protein visualized by indirect immunofluorescence.  
 
Figure 3 
HELZ interacts with the poly(A)-binding protein (PABP) 
GST pull-down using glutathione-sepharose beads was conducted by incubating crude 
HeLa cell lysates with recombinant GST, GST-Paip2106-127 and GST-HELZ1023-1199 
(A), GST and the indicated GST-HELZ fragments (D), or crude HEK293 cell lysates 
with GST and GST-PABP554-636 (C). Hypoxic HeLa cell lysates were incubated with 
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GST or GST-HELZ1023-1199 (B). Eluates were subjected to SDS-PAGE and 
immunoblotting using the indicated antibodies.  
 
Figure 4 
Translation of a luciferase reporter gene plasmid is regulated by HELZ 
(A) HeLa cells were transiently co-transfected with the indicated amounts of HELZ or 
a control expression vector together with pRL-SV40 renilla luciferase reporter 
vectors, and cultivated for 48 hours before relative luciferase activities were 
determined (upper panel). HELZ protein expression levels were controlled by 
immunoblotting (lower panel). (B) Renilla luciferase mRNA was measured by RT-
qPCR from total RNA extracted in a duplicate experiment presented in (A). Prior to 
RT, RNA was DNase-treated to digest possibly remaining plasmid DNA. Renilla 
mRNA levels were normalized to ribosomal protein L28 mRNA levels. (C) MCF-7 
cells were transfected with the indicated siRNA oligonucleotides and 24 hours later 
with pRL-SV40, and cultivated for 48 hours before relative luciferase activities were 
determined (upper panel). HELZ knock-down efficiency was controlled by 
immunoblotting. Results are presented as mean values ± standard error of the mean of 
n = 3 (A) and n = 6 (C) independent experiments, respectively.  
 
Figure 5 
HELZ regulates global protein translation 
(A) HeLa cells were transfected with 3 µg of the indicated constructs and 48 hours 
later pulse-labeled with [35S]-methionine for 1 hour. Incorporated radioactivity was 
measured by scintillation counting following TCA precipitation and results were 
normalized to total protein levels (left panel). Protein overexpression was controlled 
by immunoblotting (right panel). (B) Schematic depiction of the different HELZ 
mutations (upper panel). HeLa cells were co-transfected with the indicated HELZ 
constructs together with pRL-SV40 and cultivated for 48 hours before luciferase 
activities were determined and normalized to total protein concentrations (lower left 
panel). Expression of V5-tagged constructs was controlled by immunoblotting (lower 
right panel). (C) HeLa cells were transfected with mock control, HELZ or HELZ in 
combination with PABP siRNA oligonucleotides and analyzed as described under 
(B). Expression of the transfected vectors and PABP knock-down efficiencies were 
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controlled by immunoblotting (right panel). Results are presented as mean values ± 
standard error of the mean of n = 3 independent experiments.  
 
 
Figure 6 
HELZ suppression limits cellular proliferation, ribosomal protein S6 
phosphorylation and initiation of translation 
(A) HeLa cells were transfected with the indicated siRNA oligonucleotides and cell 
numbers were assessed every 24 hours using an automated cell counter. (B) 
Immunoblot analysis of HeLa cells transfected with two different HELZ siRNA 
oligonucleotides and harvested at indicated time points after transfection (left panel). 
The experiment was performed three times independently and the pS6 band intensities 
were quantified 48 hours after transfection (right panel). (C) Protein levels of HELZ, 
p-S6 and total S6 in stable shRNA control (shctrl) or shRNA HELZ expressing cells 
were analyzed by immunoblotting. (D) Representative polysomal profile (n=3) of 
HeLa cells transfected with control or HELZ siRNA oligonucleotides.  
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Supporting Figure S1 
Human hepatoma HuH7 cells were growth-arrested in G1 phase by incubation with 5 
µg/ml aphidicolin for 36 hours and released from G1 phase by aphidicolin removal. 
At time points 0, 4, 8 or 12 hours later, cells were fixed with 4% (w/v) 
paraformaldehyde. Cell cycle progression verified by propidium iodide (PI) staining 
and FACS analysis (left panel). HELZ subcellular localization was visualized by 
indirect immunofluorescence and nuclei were stained with Dapi (right panel).  
 
Supporting Figure S2 
Crude HeLa cell lysates were incubated with recombinant GST, the indicated GST-
HELZ fragments, GST-HIF-1α530-826 as well as GST-Paip2106-127 and GST pull-down 
was conducted using glutathione-sepharose beads. Eluates were subjected to SDS-
PAGE and immunoblotting.  
 
Supporting Table 1 
Overview of proteins with two conserved LxxLAP motifs 
Using the PROSITE pattern search tool [53] the Swiss-Prot database was searched for 
proteins containing two LxxLAP motifs. Conservation analysis across 33 species was 
subsequently performed using the MULTIZ whole-genome multiple alignment 
algorithm [54] implemented in the UCSC Genome Browser [55].  
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Abbreviations used: DMEM, Dulbecco’s modified Eagle’s medium; DMOG, 
dimethyloxalylglycine; GST, glutathione S-transferase; HELZ, helicase with zinc 
finger domain; HIF, hypoxia-inducible factor; ODD, oxygen-dependent degradation; 
PABP, poly(A)-binding protein; PHD, prolyl-4-hydroxylase domain enzyme; 
RT-qPCR, reverse transcription quantitative PCR; SG, stress granule; pVHL, von 
Hippel-Lindau tumor suppressor protein.  
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Abstract 
Transcriptional activation of oxygen-dependent genes by heterodimeric hypoxia-
inducible transcription factors (HIFs) is a crucial step in the adaptation of mammalian 
cells to low oxygen. HIF-α subunits are constantly expressed but the proteins rapidly 
degraded under normoxic conditions. A prerequisite for this oxygen-dependent 
degradation is the hydroxylation of specific prolyl residues by the 
prolyl-4-hydroxylase domain (PHD) enzymes. In hypoxia, prolyl hydroxylation 
reduction leads to stable HIF-α proteins and transcriptionally active HIF complexes. 
By applying yeast 2-hybrid screening to identify novel PHD2 interacting proteins we 
discovered three novel PHD2-interacting proteins: HELZ, ZBTB3 and KIAA0556. 
Direct interaction between these three proteins and PHD2 could not be confirmed in a 
GST pull-down assay, suggesting indirect interaction with PHD2 via a larger protein 
complex. Since HELZ is a RNA helicase we tested if HELZ affects the HIF 
transcriptional activity. HELZ did not affect HIF-dependent reporter gene regulation 
in the luciferase reporter cell line HRB5, suggesting that HELZ is not required for 
HIF-dependent transcriptional regulation. Even though HELZ interacts with the 
poly(A) binding protein it does not localize within stress granules after exposing cells 
to heat shock. 
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Introduction 
Oxygen is a key substrate in cellular metabolism and insufficient oxygen availability 
can lead to cellular dysfunction or even cell death. To ensure adequate tissue 
oxygenation, aerobic organisms developed a variety of physiological responses to 
variation in oxygen availability. These involve the cardiovascular and respiratory 
system as well as cellular adaptation processes. Central to the cellular adaptation is 
the transcriptional activation of oxygen-regulated genes by the heterodimeric 
hypoxia-inducible transcription factor HIF that binds to a specific hypoxia-response 
element (HRE) on the DNA [109]. HIF-α and HIF-β proteins are continuously 
synthesized independent of oxygen tension, but the HIF-α protein undergoes oxygen-
regulated degradation [3]. Under normoxic conditions two prolines within the ODD 
domain are hydroxylated by specific prolyl hydroxylases enabling the binding of the 
von Hippel-Lindau tumor suppressor protein (pVHL), a substrate recognition 
component of an E3 ubiquitin ligase complex, to the HIF-α subunit [3]. HIF-α gets 
ubiquitinated and subsequently targeted to the 26S proteasome for degradation [4, 5]. 
Under hypoxic conditions the prolyl hydroxylation reaction is inhibited, the 
interaction of pVHL with the HIF-α subunit abolished, resulting in HIF-α 
accumulation in the nucleus, dimerization with HIF-β, and induction of target gene 
expression [119, 125-127]. 
The proly-4-hydroxylase family consists of three members termed 
prolyl-4-hydroxylase domain (PHD) 1, PHD2 and PHD3 [6]. These three isoforms 
differ in their tissue expression and subcellular localization [149, 151]. It is postulated 
that PHD2 is the main regulator of HIF-α [7]. 
In the last few years a number of novel PHD interactors have been described. This 
includes novel PHD hydroxylation targets, but also proteins that regulate PHD 
function such as enzymatic activity or stability. For example, it has been shown by 
mass spectrometry analysis that the RING finger E3 ubiquitin ligase seven in absentia 
homolog 2 (SIAH2) interacts with the PHDs and that SIAH exhibits highest degree of 
binding with PHD3, but also associates strongly with PHD1 and to a much lesser 
extent with PHD2 [186]. In the same publication it has been shown that PHD3 
stability is regulated by SIAH2 via targeting of PHD3 for proteasomal degradation 
[186]. Other proteins have been described to be novel PHD targets. For example, 
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siRNA-mediated knock down of PHD1 and PHD2 as well as treatment of cells with 
the PHD inhibitor DMOG resulted in NFκB induction [181]. Furthermore, 
overexpression of PHD1 decreased cytokine-stimulated NFκB reporter activity [181]. 
This PHD-dependent regulation of NFκB function might involve IKKβ since hypoxia 
increases its expression and activity. Interestingly, IKKβ contains an LxxLAP motif 
and site-directed mutagenesis of the proline residue resulted in loss of hypoxic 
inducibility, suggesting that IKKβ might be a novel PHD hydroxylation target. 
Another protein that has been shown to be hydroxylated in a PHD-dependent manner 
is Rpb1 [189]. Rpb1 can bind PHD1 and PHD2, and PHD1 was necessary for 
oxidative-stress-induced P1465 hydroxylation [178, 189]. Our laboratory recently 
discovered in a yeast 2-hybrid screen that FK506-binding protein (FKBP) 38, a 
peptidyl-prolyl cis/trans isomerase (PPIase), interacts specifically with PHD2 and 
functions as an adaptor protein mediating interaction of PHD2 with the proteasome 
leading to the degradation of PHD2 [187, 188]. 
Besides FKBP38, we identified helicase with zinc finger (HELZ), KIAA0556 and 
Zinc finger and BTB-domain containing (ZBTB) 3 as novel PHD2-interacting 
proteins. HELZ is putative RNA helicase and we previously reported that it interacts 
with the poly(A) binding protein (PABP) to promote protein translation leading to 
increased cell proliferation and ribosomal protein S6 phosphorylation [Hasgall et al., 
submitted for publication]. Furthermore, tagged-HELZ protein has been shown to 
co-immunoprecipitate with co-transfected histone methyltransferases Smyd2 and 
Smyd3 and a functional role as adaptor molecule to RNA polymerase II has been 
suggested [63, 64]. KIAA0556 and ZBTB3 have yet unknown functions. 
In this report we analyze these interactions in vitro using biochemical as well as 
cellular interaction assays. We investigate the regulation of HELZ subcellular 
localization at different cell culture conditions and tested the involvement of HELZ in 
HIF transcriptional activity. 
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Results 
Novel PHD2-interacting proteins 
To identify novel PHD2-interacting proteins a yeast 2-hybrid screen of a human brain 
cDNA library using PHD2 as bait was performed. A total of 2x106 individual 
transformants were screened and we found three proteins to interact with PHD2: 
HELZ, KIAA0556 and ZBTB3. In addition, the yeast 2-hybrid screens revealed that 
the interaction domain for HELZ is located between amino acid 1727 and 1942 and 
the interaction domain for KIAA0556 between amino acid 1098 and 1625. To confirm 
our findings in a yeast-independent interaction assay, we performed a GST pulldown 
assay. The novel PHD2-interacting proteins were recombinantly expressed as GST-
fusion proteins (GST-HELZ1727-1942, GST-KIAA055561098-1625 and GST-ZBTB3) in 
bacteria and incubated with IVTT-expressed 35S-labeled PHD2. GST-HIF-1α530-826 
and GST-HIF-2α404-569 served as positive controls and GST as negative control. 
Whereas the HIF-α fragments associated strongly with PHD2 the HELZ, KIAA0556 
and ZBTB3 only showed a weak interaction signal suggesting that these proteins 
associated weakly or even indirectly via a protein complex with PHD2 (Figure 1A). 
The most interesting of the three novel interactors was HELZ since it contains similar 
to HIF-α two conserved LxxLAP motifs [Hasgall et al., submitted for publication]. To 
confirm the interaction of HELZ with PHD2 and to test if HELZ also interacts with 
PHD1 and PHD3 in a mammalian system, we performed a mammalian 2-hybrid 
assay. p53, together with the polyomavirus coat protein (CP), served as a negative 
control and FKBP38, together with PHD2 served as positive control. Since the 
HIF-2α protein is only stable under hypoxic condition interaction with PHD2 can only 
be observed under hypoxic condition [187]. Since HELZ protein abundance may also 
be regulated hypoxically we tested the HELZ interactions with the PHDs under 
hypoxic and PHD-inhibiting conditions using the PHD-specific inhibitor DMOG. To 
our surprise no interaction could be observed between HELZ and PHD2 as well as 
with PHD1 and PHD3 (Figure 1C). Even though interaction of HIF-2αODD with 
PHD2 was greatly enhanced under hypoxic or PHD-inhibiting conditions, no 
interactions could be observed between HELZ and the three PHD isoforms. These 
findings suggest that HELZ does not interact with the PHDs in mammalian cells in 
vivo.  
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To test interaction of HELZ with PHD2 in a different mammalian system we 
performed a pull-down assay in HeLa cell lysates using recombinant GST-tagged 
HELZ fragments and anti-PHD2 antibodies allowing us to test interaction with the 
endogenous PHD2 protein. GST-HIF1530-826 and GST alone served as positive and 
negative control, respectively. Furthermore, it has been shown that 20 residues long 
HIF-1α peptides suffice for both site-specific proline hydroxylation and subsequent 
binding to VHL [176]. In addition, the HELZ LxxLAP motifs do not reside within the 
C-terminal interaction domain. Hence, we tested if HELZ interacts with PHD2 
through their highly conserved N-terminal LxxLAP motif. No interaction of HELZ 
with PHD2 was observed neither through the interaction site discovered in the yeast 
2-hybrid screens nor through the LxxLAP motif (Figure 1C). 
In summary, the interaction of HELZ with PHD2 observed in the Y2H was not 
confirmed in a mammalian system using overexpressed or recombinant protein. 
Furthermore, also the LxxLAP motif does not promote interaction with PHD2 
suggesting that HELZ LxxLAP motifs may not be novel hydroxylation sites for 
PHD2. 
 
 
HELZ involvement in HIF transcriptional activity 
We previously demonstrated that HELZ protein levels are not hypoxically regulated 
[Hasgall et al, submitted for publication]. In a further attempt to demonstrate a role for 
HELZ in the context of hypoxia we performed a HIF-dependent reporter gene assay 
under hypoxic condition. For this purpose we performed a HELZ-specific transient 
knock down in HRB5 cells, a cell line derived from Hep3B that was stably transfected 
with a hypoxia responsive luciferase reporter construct [190]. Knock down of PHD2 
served as positive control. Whereas siRNA mediated knock down of PHD2 induced 
HIF-dependent transcript even under normoxic condition HELZ knock down had no 
effect, neither under normoxic nor under hypoxic conditions (Figure 2A). Knock down 
efficiencies of HELZ and PHD2 were measured by RT-qPCR (Figure 2B). In 
summary, HELZ is not involved in hypoxia-induced, HIF-dependent gene 
transcription. 
It has been shown previously in our group that stable knock down of PHD2 in MCF7 
cells results in normoxic HIF-1α accumulation [191]. We were wondering if HELZ 
protein levels accumulate under the same conditions. For this purpose we measured 
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HELZ protein levels in PHD2-silenced MCF7 knock-down clones. HELZ protein did 
not accumulate in the clones suggesting that HELZ protein is not regulated by PHD2 
similar to HIF-1α (Figure 2C). 
 
 
HELZ subcellular localization 
We recently demonstrated by immunofluorescence staining of MCF7 and Huh7 cells 
that HELZ is mainly expressed within the cytoplasm [Hasgall et al, submitted for 
publication]. To confirm this data with a different method, we performed biochemical 
fractionation of MCF7 and HEK293 cells into cytoplasmic and nuclear fractions and 
performed immunoblotting. Consistent with our immunofluorescence findings, HELZ 
protein was mainly expressed within the cytoplasm (Figure 3A). Immunostaining for 
HELZ in MCF7 and HEK293 cells also confirmed this data (Figure 3B).   
 
 
Characterization of HELZ association with SMYD3 
It has previously been shown that HELZ interacts with the methyl transferase SMYD3 
[63]. In their study, HELZ was shown to be an adaptor protein bridging SMYD3 with 
the RNA polymerase II. However, no functional significance of this bridging function 
has yet been demonstrated. In an attempt to spread some light on the function of 
HELZ in the context of SMYD3 activity we tested the role of HELZ in the induction 
of the SMYD3 target genes. In a first step we overexpressed SMYD3 in HEK293 
cells and measured the expression of the three SMYD3 target genes 
CCAAT/Enhancer Binding Protein (C/EBP) δ, Endothelin Converting Enzyme-Like 
(ECEL) 1 and Phosphoinositide-3-Kinase, catalytic, beta polypeptide (PIK3CB) by 
RT-qPCR. To our surprise none of the published SMYD3 target genes were 
significantly induced upon overexpression of SMYD3 (Figure 4A). Overexpression of 
SMYD3 was confirmed by immunoblotting (Figure 4A, bottom right panel).  
In the same publication it was demonstrated by immunohistochemical staining of 
Huh7 cells with an anti-SMYD3 antibody that the subcellular localization of SMYD3 
is altered by the density of the cell culture. In subconfluent cells, SMYD3 is expressed 
within the nucleus whereas in confluent cells within the cytoplasm. Since RNA 
helicases are known to shuttle between nucleus and cytoplasm [192-194] we were 
wondering if HELZ changes its subcellular localization similar to SMYD3. We 
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cultured Huh7 cells at different densities and measured HELZ localization by 
immunofluorescence using HELZ-specific antibodies. HELZ remained cytoplasmic 
independent of cell culture density (Figure 4B), suggesting that HELZ is not involved 
in the cell culture density-dependent alteration of SMYD3 subcellular localization. 
 
 
HELZ and stress granules 
In mammalian cells, different types of stress including ultraviolet (UV) irradiation, 
heat shock and oxidative stress inhibit translation of bulk mRNA, which aggregates in 
cytoplasmic structures known as stress granules (SGs) [195]. It has been shown that 
the poly(A) binding protein (PABP) resides within this stress granules during cellular 
stress such as heat shock [196]. To analyze whether HELZ might play a role in the 
context of stress granules we exposed HeLa cells to heat shock for two hours and 
detected HELZ subcellular localization by immunofluorescence. Whereas PABP was 
found within stress granules after heat stress HELZ was not (Figure 5). To our 
surprise, contrary to other tested cell lines, HELZ was localized in control cells within 
the nucleus as well as cytoplasm. Interestingly, after heat stress HELZ localized solely 
within the cytoplasm. 
In summary, HELZ does not relocalize into stress granules during heat shock. 
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Discussion 
A constant oxygen supply is crucial for the maintenance of an adequate energy 
metabolism since oxygen is the final electron acceptor in oxidative phosphorylation, 
the major process by which cells produces energy in the form of ATP. Central in the 
molecular adaptation to reduced oxygen supply is the hypoxia-inducible transcription 
factor HIF. HIF belongs to the basic helix-loop-helix/Per-ARNT-Sim (bHLH/PAS) 
family of transcription factors and is composed of a HIF-α and a HIF-β subunit. 
HIF-α and HIF-β proteins are continuously synthesized independently of oxygen, but 
the HIF-α proteins undergo oxygen-regulated degradation [3]. Central in this 
regulation is the function of a family of HIF proly-4-hydroxylases that use oxygen as 
substrate to hydroxylate two prolines (402 and 564) within the HIF-α protein, 
enabling pVHL binding resulting in HIF-α ubiquitination and proteasomal 
degradation [3-5]. Since the discovery of the PHDs, a lot of effort has been invested to 
find novel PHD-interacting proteins that might be novel hydroxylation targets or may 
act upstream of the PHDs. Rpb1, a RNA polymerase II subunit and IKKβ have been 
shown to be novel PHD hydroxylation targets [181, 189]. ATF 4 was found to interact 
with PHD3 and ATF4 protein stability were increased by hypoxia or PHD inhibition 
[185]. Upstream of PHD, the melanoma antigene gene protein (MAGE) 11 was found 
to inhibit PHD2 function without affecting PHD protein levels and our group found 
by using PHD2 as bait in a yeast 2-hybrid screen that FKBP38 interacts specifically 
with PHD2 and that it regulates PHD2 protein stability [187, 197]. In the same yeast 
2-hybrid screen three other proteins were discovered to interact with PHD2: HELZ, 
KIAA0556 and ZBTB3. The interaction was confirmed by yeast retransformation. 
Interestingly, interaction could not be confirmed in a pull-down assay using 
recombinant proteins. This suggests that these novel PHD2-interacting proteins may 
not interact directly with PHD2, but are found in a protein complex together with 
PHD2. In this regard, it has been postulated that PHD2 is part of a large heteromeric 
complex [187]. Furthermore, PHD2 has been shown to coimmunoprecipitate with the 
RNA polymerase II subunit Rpb1, and an independent study showed that the same 
subunit interacts with exogenously-expressed HELZ protein [63, 189]. However, also 
using a mammalian 2-hybrid assay and pulldown assay in HeLa cell lysates did not 
confirm the interaction of HELZ with PHD2. Since the interaction observed in the 
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yeast 2-hybrid cannot be confirmed in a mammalian system the question arises if the 
observed yeast 2-hybrid interaction is a false positive or not. In our yeast 2-hybrid 
PHD2 was fused to a GAL4-DBD and HELZ to VP16-AD. It would be interesting to 
test if HELZ and PHD2 still interact if the tags would be exchanged fusing HELZ to 
the GAL4-DBD and PHD2 to the VP16-AD. Furthermore, yeast 2-hybrid interaction 
assay should be repeated in another yeast strain to exclude that the interaction of 
HELZ with PHD2 is strain specific. Besides our yeast 2-hybrid screen, HELZ has 
already been found in two different yeast 2-hybrid screens that were performed by 
two different groups independently [63, 198]. One of these groups actually found 
HELZ to be a false positive [198]. Furthermore, HELZ has been found to interact in 
mammalian cells with several proteins, namely SMYD3, SMYD2, RNA Polymerase 
II, and PABP and possibly with HYD since many PAM2-motif containing proteins 
interact with HYD [63, 64]. Proteins that have several interaction partners (e.g. heat 
shock proteins, ribosomal subunits) have specific structures that facilitate interaction 
with other proteins even when the interaction is not of functional significance. An 
exact determination of the three-dimensional structure of HELZ may reveal such 
structures. We show here that HELZ induces global translation. Expression of HELZ 
in yeast cells may therefore increase basal translation of the reporter genes used in our 
yeast 2-hybrid screen. Global protein translational rate should therefore be measured 
under the conditions used in our screen. 
Adaptation to environmental changes is a great challenge for a cell since the changes 
are not always predictable. Cellular stress often results in translational arrest and the 
accumulation of untranslated mRNA in specific cytoplasmic foci termed stress 
granules (SGs) [199]. Only transcripts of dispensable mRNAs are stored within the 
granules, the translation of stress-induced transcripts such as for heat shock proteins is 
maintained or even enhanced [200]. Besides mRNA, these SGs usually contain 
members of the translation initiation machinery including the PABP [196]. We 
previously showed that HELZ interacts with PABP and that it is involved in the 
initiation of translation. Our data presented here indicate that HELZ does not 
accumulate within stress granules as shown by immunofluorescence. It would be 
interesting to test if HELZ plays a role in the translation of mRNAs that are involved 
in the adaptation to heat stress and are therefore not stored in stress granules. The 
change in subcellular localization during heat shock would suggest that HELZ plays 
an active role in the adaptation to heat stress.  
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In summary, in this work we show that the existence of even two highly conserved 
LxxLAP motifs cannot be taken as a prerequisite for the interaction with PHD2 and 
involvement in the HIF transcriptional activity. We show that HELZ, even though 
involved in translation initiation, does not translocate upon heat shock into stress 
granules suggesting that HELZ does not play a role in the surveillance of dispensable 
mRNAs during cellular stress. 
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Materials and methods  
Unless otherwise indicated, cloning work was carried out using Gateway technology 
(Invitrogen, Basel, Switzerland) as described previously [187]. pDONR-HELZ1727-
1942
, pDONR-KIAA05561098-1625 and pDONR-ZBTB3 originated from the yeast 
2-hybrid screen as described previously [187]. The HELZ1-1942 and SMYD3 cDNA 
was obtained from Origene (LabForce, Nunningen, Switzerland) and cloned into 
pENTR4 (Invitrogen). To generate fusion protein expression vectors, entry or donor 
vectors were recombined in vitro with destination vectors using LR Clonase 
recombination enzyme mix (Invitrogen). Glutathione S-transferase (GST) expression 
vector pDEST15 was used to generate GST-tagged fusion protein. The plasmids used 
to generate recombinant GST-HIF-1α530-826 and recombinant GST-HIF-2α404-569 were 
described previously [187, 201]. To generate expression plasmids for mammalian 2-
hybrid analysis pM-DEST and pVP16-DEST were used [187].¨ 
 
Plasmids 
Human MCF-7 breast carcinoma, human HeLa cervical carcinoma, human embryonic 
kidney HEK293 cells and HRB5 cells were cultured in high-glucose Dulbecco’s 
modified Eagle’s medium (DMEM) (Sigma, Buchs, Switzerland) as described 
previously [201], and human hepatoma HuH-7 cells were cultured in RPMI-1640 
[202]. For hypoxic conditions, O2 levels were decreased to 0.2% with N2 in an 
oxygen-controlled incubator (Binder, Tuttlingen, Germany). Transfections were 
performed using polyethylenimine (Polysciences, Warrington, PA, USA) as described 
previously [162] or Lipofectamine2000 (Invitrogen). Cellular nuclear extracts and 
cytoplasmic fractions were prepared as previously described [203]. 
 
Yeast 2-hybrid 
Yeast 2-hybrid screen was performed as described previously [187]. 
 
 
Reporter gene and mammalian 2-hybrid 
The HIF-dependent firefly luciferase reporter cell line HRB5 was generated as 
described previously [190]. Cells were transfected with 100 nM of siRNA duplex 
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oligonucleotides using Lipofectamine 2000 (Invitrogen). 24 hours post-transfection 
cells were equally distributed and exposed to 20% or 0.2% oxygen for another 16 
hours. Cells were washed twice in ice-cold PBS and luciferase activity was measured 
using the luciferase reporter assay system according to the manufacturer's instructions 
(Promega). Mammalian 2-hybrid analysis was performed as described previously 
[187]. 
 
Protein expression and purification 
GST and GST fusion proteins were expressed in Escherichia coli BL21-AI by 
induction with 0.025% arabinose for 4 hours and affinity purified using glutathione-
Sepharose beads (GSTrap FF; GE Healthcare, Dübendorf, Switzerland) according to 
the manufacturer's instructions. 
 
GST pull-down 
GST pull-down assay was performed as describe previously [187]. 
 
Immunoblotting 
Immunoblot analyses were performed as described previously [204]. Antibodies used 
were mouse monoclonal antibody (mAb) anti-HELZ (Abnova, LucernaChem, Luzern, 
Switzerland), mAb anti-β-actin (Sigma), rabbit polyclonal antibody (pAb) anti-SP1 
(Santa Cruz Biotechnology, LabForce, Nunningen, Switzerland), pAb anti-PHD2 
(Novus Biologicals) and pAb anti-SMYD3 (Abcam). 
 
mRNA quantification 
Total cellular RNA was extracted as described previously [187]. First-strand cDNA 
synthesis was performed with 1 µg total RNA using reverse transcriptase (RT) and 
mRNA levels were measured by RT-qPCR using internal calibration standards and a 
SybrGreen qPCR reagent kit (Sigma) in combination with the MX3000P light cycler 
(Stratagene). To verify RNA integrity and equal input levels, ribosomal protein L28 
mRNA was determined, and the data were expressed as ratios relative to L28 mRNA 
levels. 
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Immunofluorescence microscopy 
Indirect immunofluorescence microscopy was performed as described previously 
[187]. 
 
Statistical analysis 
Where not otherwise indicated, results are presented as mean values ± standard error 
of the mean of at least n = 3 independent experiments. All statistical tests were 
performed and graphed using GraphPad Prism v4.0 software (*, P < 0.05; **, P < 
0.01).  
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Figure legends 
Figure 1: HELZ, KIAA0556 and ZBTB3 interaction with PHD2 
(A)  IVTT 35S-labeled PHD2 was incubated with GST alone, GST-HIF-1α530-826, 
GST-HIF-2α404-569, GST-KIAA05561098-1625, GST-ZBTB3 or GST-HELZ1727-1942. 
Bound proteins were pulled down and visualized by phosphorimaging. 
 (B) HeLa cells were transiently transfected with Gal4-DBD and VP16AD fusion 
protein vectors and a Gal4 response element-driven firefly luciferase reporter, as well 
as a renilla luciferase control vector. 36 hours post transfection cells were exposed to 
20% O2, 0.2% O2 or 2 µM DMOG and luciferase reporter gene activities were 
determined 18 hours later. Mean values plus standard errors of the mean are shown 
for three independent experiments performed in triplicate. 
(C) GST pull-down using glutathione-sepharose beads was conducted by 
incubating crude HeLa cell lysates with recombinant GST, GST-HELZ1727-1942, GST-
HELZ1023-1199, GST-HELZ1023-1199F1107A, GST-HELZ10231199P1105A and GST-HIF-
1α. 
 
Figure 2: HELZ involvement in HIF-transcriptional activity 
(A) HRB5 cells were transiently transfected with the indicated siRNA 
oligonucleotides. HRE-reporter activity was determined by measuring luciferase 
activity and normalization to protein concentrations. 
(B)  Knock-down efficiency was tested by measuring HELZ and PHD2 mRNA 
levels in the HELZ or PHD2-silenced HRB5 cells using RT-qPCR. 
 (C) HELZ protein levels were measured in MCF7 wild-type cells (wt) and stable 
PHD2-silenced MCF7 clones by immunoblotting using anti-HELZ antibodies. Knock-
down efficiently was tested with anti-PHD2 antibodies and β-actin was used as 
loading control. Two independent experiments are shown. 
 
Figure 3: HELZ subcellular localization 
(A) Cytoplasmic fractions (C), nuclear extracts (N) and whole cell extracts (WCE) 
were separated by SDS PAGE followed by immunoblotting and detection with anti-
HELZ antibodies. The stable HELZ shRNA clone 4-10 and the Hodgkin’s lymphoma-
derived cell line DEV containing a homozygous deletion on chromosome 17 served as 
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controls for reduced and absent HELZ protein levels, respectively. Following 
incubation with the anti-HELZ antibody the membrane was incubated with anti-Sp1 
and anti-β-actin control antibodies. 
(B)  Human hepatoma Huh7 cells were culture at the indicated concentration and 
fixed with 4% of paraformaldehyde. HELZ subcellular localization was visualized by 
indirect immunofluorescence and nuclei were stained with DAPI. 
 
Figure 4: SMYD3 target gene expression 
(A) HEK293 cells were transiently co-transfected with the indicated amounts of 
SMYD3 or a control expression vector and mRNA levels of the indicated SMYD3 
target genes was measured by RT-qPCR. SMYD3 overexpression efficiency was 
measured by immunoblotting. 
(B) HEK293 cells were culture at the indicated cell culture densities and fixed 
with 4% paraformaldehyde. HELZ subcellular localization was visualized by indirect 
immunofluorescence and nuclei were stained with DAPI. 
 
Figure 5: Effect of heat shock on HELZ subcellular localization 
HeLa cells were heat shocked (46°C) for 2 hours and subsequently fixed in 4% 
paraformaldehyde. HELZ and PABP subcellular localization was visualized by 
indirect immunofluorescence and nuclei were stained with DAPI. 
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Part 6:  Discussion 
Protein expression is one way how cells regulate protein activity. Protein expression is 
tightly regulated on several levels including transcription, translation and also post-
translational modifications. The hypoxia-inducible factor HIF is strongly regulated on 
its post-translational level through a family of prolyl-4-hydroxylases (PHDs) that 
hydroxlyate the HIF-α subunit at specific prolines resulting in the destruction of the 
HIF-α protein in the proteasome. Under low oxygen conditions, PHD function is 
impaired leading to a stable HIF-α subunit resulting in the formation of a 
transcriptionally active HIF protein. Since the discovery of the PHDs the question 
arose if the PHDs have hydroxylation targets other than HIF-α or if PHD interaction 
partners exist that regulate the PHD catalytic activity or abundance. To find such 
novel PHD interactors, we performed a yeast 2-hybrid screen using PHD2 as bait. 
There are three PHD isoforms, PHD1, PHD2 and PHD3 and we decided to center our 
focus on PHD2, since it has been shown that it is the major regulator of the HIF-α 
subunit [6, 7]. We discovered three novel PHD2-interacting proteins: helicase with 
zinc finger domain (HELZ), zinc finger and BTB domain containing protein 
(ZBTB) 3 and KIAA0556.  
In the HIF-α protein both hydroxyl prolines are located within a LxxLAP motif [175]. 
Besides HIF-α, two other proteins have been described to be hydroxylated in the 
context of a LxxLAP motif namely Rpb1 and IκB kinase-β [181, 189]. We used 
bioinformatic research tools to analyse the novel interactors for LxxLAP motifs and 
found that HELZ contains two evolutionary conserved LxxLAP motifs. ZBTB3 and 
KIAA0556 do not contain any LxxLAP motifs. Based on this observation we decided 
to keep our main focus on HELZ. HIF-α interacts with all three PHDs and we also 
studied the interaction of HELZ with PHD1, PHD2 and PHD3. However, none of the 
interaction assays used in this study could clearly demonstrate the association of 
HELZ with any of the PHDs in mammalian cell systems. This is surprising, but could 
be explained by the fact that we performed most of our assays under normoxic 
conditions and it is possible that under these conditions the HELZ protein is not stable 
and interaction can therefore not be detected. The existence of the two LxxLAP 
motifs would support such an idea. To investigate this option, we tested HELZ protein 
expression levels under hypoxic or PHD-inhibiting conditions. We discovered that 
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HELZ protein levels remain unaffected under these conditions. HELZ protein 
abundance is therefore not regulated by the PHDs and this finding suggests that even 
the existence of two conserved LxxLAP motifs cannot be taken as prerequisite for 
oxygen-dependent protein degradation or interaction with the PHDs. This point is 
supported by our discovery that, besides HIF-α and HELZ, only two other proteins 
contain two evolutionary conserved LxxLAP motifs namely CCR4-NOT transcription 
complex (CNOT1) and faciogenital dysplasia protein (FGD1) and none of them have 
yet been described in the context of oxygen-dependent regulation or PHD-interaction. 
Our observation is further supported by the finding of Huang and colleagues that, 
besides the hydroxylacceptor proline, none of the amino acids within the LxxLAP 
motif are required [176]. In another report, it has been shown that an amino acid 
substitution of the two leucines in the LxxLAP motif of a 20 residue motif had almost 
no effect on the substrate properties of the peptide [205]. In fact, of all the residues 
within the LxxLAP motif of HIF-α, only the hydroxylacceptor proline is relevant for 
substrate binding [206]. Interestingly, several different groups have shown that 
specific amino acids residues N-terminal or C-terminal of the LxxLAP motif are 
relevant for hydroxylation further supporting our notion that the existence of an 
LxxLAP motif alone is not enough for the prediction of oxygen-dependent regulation 
of a specific protein. For example, it has been shown that three naturally occurring 
mutations within HIF-2α (G537W, M535V and G537R) impair the binding of HIF-2α 
to PHD2 and VHL [207]. Another study showed that leucine at position 574 is crucial 
for VHL binding and VHL-mediated degradation of HIF-1α [177]. Furthermore, it has 
been shown that the substrate specificity of the PHDs is determined by a region 
relatively remote from the catalytic site [208]. These findings together with our 
observations suggest that the requirement of LxxLAP motifs for oxygen-dependent 
hydroxylation and protein degradation may be less important than originally thought. 
Besides oxygen-dependent degradation, hydroxylation may have other, up to now 
unknown functions such as activation or suppression of protein activity. To examine 
this option we first investigated the yet unknown cellular function of HELZ. The 
resolution of the functional role of HELZ was initiated by the observation that 
overexpression of HELZ protein induces a heterologous luciferase reporter gene 
construct. The luciferase transcript levels remained unchanged suggesting that HELZ 
promotes protein translation. Methionine incorporation assay confirmed a stimulatory 
function for HELZ in protein translation. Since we were particularly interested in the 
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functionality of the HELZ LxxLAP motifs, we tested if the HELZ stimulatory 
function on translation involves the prolines within the HELZ LxxLAP motifs. 
However, mutation of one or both of the potential hydroxylacceptor prolines did not 
affect the HELZ stimulatory potential on translation. From this finding we can 
conclude that the prolines within the HELZ LxxLAP motifs are dispensable for HELZ 
function. 
Regulation of protein translation is one way how cells control gene expression. This 
regulatory mechanism allows an instant response to a change in physiological 
conditions even in the absence of gene transcription. Protein translation is a four step 
process consisting of initiation, elongation, termination and ribosome recycling. Even 
though all steps are tightly regulated, translation initiation is the rate limiting step and 
the major site of regulation. The poly(A) binding protein (PABP) plays a key role in 
this regulation since it directly binds to the poly(A) tail of the mRNA resulting in the 
circularization of the mRNA due to the interaction of PABP with the eIF4F complex 
thereby facilitating translation initiation [8, 9]. Interaction with the poly(A) tail of 
mRNAs is established through the RNA recognition motifs (RRMs) within the 
N-terminal site of PABP [88]. Through its C-terminal site PABP associates with 
several of its interaction partners through their common PAM2 binding site [10]. 
These PABP interactors play a role in protein translation as well as mRNA stability 
[10]. Interestingly, HELZ harbours a PAM2 motif and the HELZ stimulatory role on 
translation may therefore be facilitated through its association with PABP. Indeed, our 
study confirmed that HELZ associates directly with PABP through its PAM2 motifs 
and indirectly with eIF4E probably via PABP. To our surprise the HELZ stimulatory 
effect on translation seemed to be independent of its interaction with PABP. However, 
we tested the possible involvement of PABP for the HELZ stimulatory activity on 
translation by mutating the PAM2-binding site of HELZ with PABP. It has been 
shown that PAIP1 interacts with PABP not only through its PAM2-binding site but 
also through another binding site termed PAM1, a motif that is composed of a 39 
mainly acidic and hydrophobic amino acids [91]. It is interesting to note that the 
PAM1 site binds PABP with even a higher affinity than the PAM2 site [91]. Since the 
PAM1 binding site is relatively large and poorly defined (the physical basis of the 
PABP-PAM1 interaction site is not known) and seems to be different for Paip1 and 
Paip2 it is difficult to predict if HELZ contains a PAM1 site. It is therefore possible 
that HELZ interact with PABP at a site other than PAM2 and the interaction through 
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that site may be sufficient to promote HELZ function. We verified this idea by testing 
the HELZ-stimulatory role in translation in cells that have reduced PABP protein 
levels. Also these results show that the association of HELZ with PABP is 
dispensable for the HELZ-dependent induction of the luciferase reporter. However, 
we can not exclude that HELZ interacts with other members of the PABP family that 
may compensate for the lack of PABP or may even be the functional relevant 
interactor. In this context it has been shown that Tob1 interacts with PABP and 
iPABP via its PAM2 binding site [209]. It this study it has been shown that Tob1 
interacts with iPABP and PABP and that Tob1 negatively regulates iPABP-mediated 
enhancement of translation of IL-2 mRNA. Inducible PABP received its name 
because it is rapidly upregulated in T cells and platelets upon their activation [101], 
[102]. The Genomics Institute of the Novartis Research Foundation (GNF) Atlas 
(http://biogps.gnf.org) documented that HELZ is relatively high expressed in 
lymphoid as well as myeloid cells compared to non-immune cells. This suggests that 
HELZ may play a role in iPABP function and therefore the HELZ-mediated induction 
of translation should be studied in the context of an iPABP interaction. In addition, 
since we tested HELZ function on an exogenously expressed luciferase construct it 
would be of great importance to study the function of HELZ on endogenous protein 
translation. Our global protein translation studies demonstrate a role of HELZ in 
endogenous protein translation and we also performed a polysomal profil analysis and 
observed that translation initiation is impaired in HELZ-deficient HeLa cells. It would 
be interesting to test if HELZ targets specific subsets of mRNAs harbouring 
subset-specific structures within their 5’-UTRs or, similar to Tob1, even mRNAs of 
specific genes. This could be tested by performing a gene array within the 
polyribosomes to test if certain mRNAs are differentially translated in HELZ-
deficient cells. The interaction of HELZ with PABP or possibly iPABP can then be 
tested in the context of these mRNAs.  
Nonetheless, our findings suggest that HELZ is member of the translation initiation 
complex that consists of PABP and other eukaryotic initiation factors such as eIF4E 
and bears a role in translation initiation.   
Translation initiation factors play a vital role in cell proliferation and tumorigenesis. 
For example, stable expression of eIF4E in NIH3T3 and CHO cells enhances cellular 
proliferation and promotes growth in soft agar [210]. Overexpression of eIF4GI leads 
to tumor formation in nude mice [211]. eIF4A, a RNA helicase that is central for 
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optimal translation initiation, is found to be overexpressed in human melanoma cells 
and in primary hepatocellular carcinomas [212, 213]. DHX29 has been described to 
promote translation initiation and tumorigenesis and DDX3, a RNA helicase that is 
involved in translation initiation, has been described to promote cell growth [36, 214]. 
Based on these findings and our observation that HELZ functions in translation 
initiation, we thought to test if HELZ promotes cell proliferation. Indeed, our cell 
proliferation analysis demonstrated that HELZ promotes cell proliferation in vitro. It 
would be interesting to how this stimulating effect translates into the in vivo situation. 
It has been shown that HELZ is highly expressed in multiple tissues and organs within 
the developing embryo [62] and HELZ may therefore play a role in embryonic 
development. A HELZ knock out mouse model could give some answers on that 
question. Just recently, the ribosomal protein RPL38 has been found to specifically 
induce mRNA subsets of HOX genes during embryonic development [215]. It has 
been speculated, that RNA binding proteins may assist in this process [216]. It is very 
tempting to speculate an involvement of HELZ in this process. The previous observed 
increase in HELZ expression in the developing embryo [62] and the HELZ 
perinuclear expression [Hasgall et al., submitted for publication] would support such 
an idea. As mentioned, to find HELZ-specific target genes, a gene array in 
polyribosomes from HELZ-silenced versus wild-type cells should be performed. Such 
targets could then be studied in the context of embryonic development and ribosomal 
protein function. Also, the observed effect of HELZ on cell proliferation suggests a 
role of HELZ in tumorigenesis and this can be tested with an in vivo tumor mouse 
model testing tumor formation capacity of cells deficient in HELZ. A function of 
HELZ in tumorgenesis is supported by the observation that HELZ interacts with 
SMYD3, a methyltransferase that induces the expression of several oncogenes, and 
acts as a bridging protein between SMYD3 and RNA polymerase II [63].  
The mTOR signaling pathway plays a central role in the control of cell growth and 
proliferation [217]. Most of the main targets of mTOR are components of the 
translation machinery, mainly initiation factors [218]. This includes eIF4B, eIF4G, 
eIF4E and S6K, the main kinase phosphorylating the ribosomal protein S6 that is a 
critical component of the 40S ribosomal subunit. Phosphorylation of the ribosomal 
protein S6 correlates positively with an increase in cell proliferation [219]. To test if 
the HELZ stimulatory effect on proliferation involves the mTOR signaling pathway, 
we analyzed the influence of HELZ on the phosphorylation of the ribosomal protein 
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S6. Strikingly, reduced HELZ protein levels in HeLa and HEK293 cells significantly 
correlated with reduced S6 phosphorylation. This observation cannot simply be 
explained by reduced S6 protein levels since they remain unaffected. A possible 
explanation could be that HELZ has an effect on the expression or the function of a 
kinase or even phosphatase upstream of S6. Our finding that HELZ plays a role in 
translation initiation would support such an idea. Precise mapping of the expression 
levels and phosphorylation state of all proteins that have an effect on the 
phosphorylation state of S6 would lead to the discovery of proteins that are affected 
by HELZ. The mRNA of these candidates could be then studied to reveal the 
mechanism on how HELZ affects their expression. In this regard a few RNA helicases 
or RNA binding proteins have been found to target specific subsets of mRNAs. For 
instance, eIF4A is responsible for unwinding of secondary structures of the 5’ UTR 
[220]. The RNA helicase A unwinds, similarly to eIF4A, secondary structures in the 
5’ UTR but in a target specific manner through binding to complex 5′ post-
transcriptional control elements [221]. The RNA helicase VASA also targets a 
specific subset of mRNAs by binding to the 3’ UTR and thereby facilitating 
translation initiation by recruitment of eIF5B in drosophila [222]. DHX29 targets 
mRNAs that have highly structure 5’ UTRs [37]. The RNA-binding 
protein embryonic-lethal abnormal vision (ELAV/Hu) stimulates the translation of 
mRNAs that contain an internal ribosomal entry site (IRES) [223]. 
Since S6 is mainly phosphorylated by the S6 kinase that is member of the mTOR 
signaling pathway we looked at some of the central members of the mTOR pathway 
namely mTOR, AKT and S6K, but there protein expression levels were not affected 
by HELZ. However, the mTOR pathway involved dozens of proteins and therefore 
we cannot exclude the involvement of the mTOR signaling pathway.  
In summary, in the study presented herein we discovered that the putative RNA 
helicase HELZ plays a vital role in translation initiation and cellular proliferation. We 
showed that HELZ specifically modulates the phosphorylation state of the ribosomal 
protein S6. We found that HELZ contains two evolutionary conserved LxxLAP 
motifs, but these motifs are not functional since mutation of the prolines within the 
motifs does not affect HELZ protein levels or function. How HELZ mechanistically 
promotes S6 phosphorylation remains unknown, but may possibly involve the 
translation of specific subsets of mRNAs. 
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